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Summary: 
 
Age-related macular degeneration and cataract are very common causes of visual 
impairment in the elderly. Macular pigment optical density is known to be a factor affecting 
the risk of developing age-related macular degeneration but its behaviour due to light 
exposure to the retina and the effect of macular physiology on this measurement are not 
fully understood.  
Cataract is difficult to grade in a way which reflects accurately the visual status of the 
patient. A new technology, optical coherence tomography, which allows a cross sectional 
slice of the crystalline lens to be imaged has the potential to be able to provide objective 
measurements of cataract which could be used for grading purposes. 
 
This thesis set out to investigate the effect of cataract removal on macular pigment optical 
density, the relationship between macular pigment optical density and macular thickness 
and the relationship between cortical cataract density as measured by optical coherence 
tomography and other measures of cataract severity. 
 
These investigations found: 
 
1) Macular pigment optical density in a pseudophakic eye is reduced when compared to 
a fellow eye with age related cataract, probably due to differences in light exposure 
between the eyes. 
 
2) Lower macular pigment optical density is correlated with thinning of the entire 
macular area, but not with thinning of the fovea or central macula. 
 
3) Central macular thickness decreases with age. 
 
4) Spectral domain optical coherence tomography can be used to successfully acquire 
images of the anterior lens cortex which relate well to slit lamp lens sections. 
 
5) Grading of cortical cataract with spectral domain optical coherence tomography 
instruments using a wavelength of 840nm is not well correlated with other 
established metrics of cataract severity and is therefore not useful as presented as a 
grading method for this type of cataract. 
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Cataract and macular degeneration are common age related causes of vision loss which 
between them are detectable in most people to some extent in later life (Klein et al., 1992, 
2007). Age-related macular degeneration affects the ability of the central retina to detect 
light and cataract affects the ability of the eye to form an image on the retina. This research 
concerns aspects of the crystalline lens and macula.  
It will cover the effect of cataract removal and the subsequent presumed increase in macular 
light exposure on levels of macular pigment optical density (MPOD), the relationship 
between MPOD and central macula thickness and assessment of cortical cataract 
development using optical coherence tomography.  
This first chapter will cover the background knowledge regarding the macula, macular 
pigment (MP) and age-related macular degeneration. It will then cover the structure of the 
macula and its relationship to macular pigment and the development of cataract with regard 
to its potential measurement using optical coherence tomography.  
1.1: Age-related disease of the macula and macular pigment 
The macula is a region of the retina responsible for the highest resolution vision which gives 
us the ability to read print, discern details of faces and perform visually intensive tasks such 
as driving. It is defined as the central 3mm of the retina or approximately 2 optic disc 
diameters, with the macula lutea, or fovea, at the centre (Bird et al., 1995a) (Figure 1.1; Li et 
al., 2010). This area is largely responsible for our ability to perceive colour, with the majority 
of the cone receptors located there, the periphery being populated by the more light 
sensitive rods(Jonas et al., 1992). 
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Age-related macular degeneration (AMD) is the second most common cause of vision loss in 
the world after cataract, the leading cause of vision loss in the developed world (Congdon, 
2003) and the most common cause of registered blindness in the UK (Rahi et al., 2002). It is 
caused by age-related dysfunction and ultimately atrophy of the outermost layer of the 
sensory retina, the retinal pigment epithelium (RPE). The photoreceptors are embedded into 
the anterior surface of the RPE and loss of this layer leads to cell death of the 
photoreceptors and consequent loss of vision.  
Figure 1.1: The normal macula (white dashed line) and the structure of the three 
components of macular pigment: from Li et al (2010). 
AMD is currently irreversible but as its name suggests generally only affects the macula, 
leaving the peripheral retina intact (Sunness et al., 1985) (figure 1.2). It leads to severe 
difficulty with many common tasks such as reading. Some RPE dysfunction is identifiable in 
most elderly people (Bressler et al., 1989; Mitchell et al., 1995), but only a minority of those 
will experience vision loss, the critical factors being the area and location of the damage . 
Even minor damage to the fovea can lead to serious vision loss whereas atrophy not 
involving the fovea can be asymptomatic, as can significant loss of vision in only one eye 
(Jager et al., 2008). 
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Figure 1.2: Macular degeneration with geographic atrophy at the centre  surrounded by soft 
drusen. 
Macular pigment is the name given to a collection of pigments which are selectively 
accumulated in the macular region of the eye. They are yellow in colour due to their blue 
light absorbing properties and this gives the region its name, the macula lutea. Macular 
pigment optical density represents the measurable absorption of light by the MP in the 
retina.  
The yellow appearance of the fovea has been documented since 1792 and the existence of 
MP was first postulated some 150 years ago as described by Whitehead (2006) but the two 
principal components only specifically identified in the last 30 years (Bone et al., 1985). 
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The existence of MP is thought to be an evolutionary adaptation to improve glare control 
and reduce chromatic aberration. It is thought to do this by reducing light scatter by short 
wavelength blue light which would otherwise degrade the retinal image quality by passing 
unfocused scattered light through the photoreceptors (Wooten and Hammond, 2002).  
Located primarily in the axons of the cone photoreceptors where it is able to filter light 
before it reaches the photoreceptor pigments, MP is found in primates and other animals 
such as bovines, frogs and birds (Khachik et al., 2002; Li et al., 2010). It has been 
demonstrated that macular pigment improves contrast sensitivity (Nolan et al., 2011), 
improves retinal image quality through reduced chromatic aberration (Thibos, 1987), 
increases tolerance to light levels, delaying the onset of photophobia (Wenzel et al., 2006) 
and improves the recovery from high levels of light exposure (Sasaki et al., 2012). Older 
subjects with high MPOD have been shown to retain their visual sensitivity better than those 
with low MPOD (Hammond et al., 1998). 
MP also appears to have an antioxidant role and a barrier protection against oxidative 
damage caused by blue light, the highest energy light encountered by the retina, to the RPE 
and choriocapillaris (Kijlstra et al., 2012). This protection is thought to help delay the onset 
of AMD and there have been several studies which have shown a correlation between 
MPOD and AMD risk (Bone et al., 2001; Delcourt et al., 2006; Raman et al., 2012) but not all 
studies show this effect (Berrow et al., 2011; Mares-Perlman et al., 1996, 1995) (see chapter 
2 for a more comprehensive list of relevant studies).  
As AMD in humans only occurs in those largely beyond reproductive age the protective role 
may not be the evolutionary selection pressure which has led to its selective uptake. 
However, Malinow and colleagues (1980) showed that window defects and drusen like 
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abnormalities occurred in monkeys deprived of xanthophylls for just seven years. Monkeys 
with normal levels of MP have been demonstrated to develop macular degeneration at just 
19-28 years of age, unlike humans (Gouras et al., 2008). Therefore the antioxidant effect 
may be for other animals important in survival and reproduction in a way which may not 
apply to humans. 
 Oxidative damage occurs to retinal tissues from both light exposure and normal metabolic 
processes which both tend to generate reactive oxygen species , with the RPE being the most 
metabolically active tissue in the body (Feigl, 2009). It has been proven that 
supplementation with antioxidants slows the progression of some forms of AMD and 
reduces the likelihood of neovascular AMD (Chew et al., 2013). Macular pigment is thought 
to have a role in controlling oxidative damage to tissues (Barker et al., 2011; Bhosale and 
Bernstein, 2005; Chucair et al., 2007; Kernt et al., 2012) and oxidation products of the 
macular pigments Lutein and Zeaxanthin have been found in the retina confirming their 
antioxidant action (Khachik et al., 1997). The continuous phagocytosis of the pigment discs 
of the photoreceptors (figure 1.3) and high levels of unsaturated lipids are also responsible 
for the high levels of oxidative stress in this region (Sun et al., 2006). 
figure 1.3: Schematic drawing showing the 
arrangement of the photoreceptors and the 
phagocytosis of the receptor tips by the RPE. ROS 
= rod outer segments From Schraermeyer and 
Heimann (1999) 
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The pigments which make up MP are the structural isomers lutein (L), zeaxanthin (Z) and 
meso-zeaxanthin (MZ). MZ is a stereoisomer of zeaxanthin. L Z and MZ are all xanthophyll 
carotenoids and the only carotenoids to be found in the retina (Figure 1.1). Being isomers, all 
have the same chemical formula C40H56O2. These pigments have several double bonds which 
act as free radical scavengers due to the high availability of free electrons (Bone et al., 1993).  
The concentration of these pigments in the retina varies between individuals and the peak 
absorption can be measured, producing a result known as the macular pigment optical 
density, or MPOD. The distribution of these pigments is not even across the macular region 
(Bone et al., 1997) (figure 1.5) and the distribution of the pigments can also be measured 
through various methods described subsequently. The peak absorbance of MP is around 
460nm (figure 1.4) and it has been estimated that an average level of MP in humans absorbs 
between 20-40% of light at this wavelength, whereas those with a high level of MP may 
absorb up to 98% (Hammond and Caruso–Avery, 2000; Landrum and Bone, 2001).  
Figure 1.4: Absorption spectra of the lens, 
macular pigment, oxygenated and 
deoxygenated blood, and melanin. In this 
graph lens density is 0.54 at 420 nm, MPOD 
is 0.5 at 460 nm and the melanin density is 
0.8 at 500 nm. From Berendschot et al. 
(2003). 
Macular pigment is accumulated in high concentrations in the Henle fibres and inner 
plexiform layers in primate retinas and is highest in concentration at the fovea, from which it 
declines to uniform, constant density from approximately 1mm eccentricity and is 
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detectable throughout the retina using high performance liquid chromatography (Snodderly 
et al., 1984).  
There may be slightly different roles for L and Z in the retina linked to their differing 
orientations which have been observed experimentally (Sujak et al., 2000). L is proposed to 
be involved in absorbing short wavelength radiation penetrating retina membranes and Z 
protecting the lipid phase against oxidative damage. The ratio of L and Z also varies across 
the retina with Z being dominant in the fovea and the ratio being biased towards L with 
increasing eccentricity (Bone et al., 1997). MZ is only present at the central fovea and is the 
most potent antioxidant of the three (Bhosale and Bernstein, 2005). 
Figure 1.5:  The distribution of yellow macular carotenoids in the fovea of a monkey. The 
fovea is generally slightly smaller in humans. From Kijlstra et al. (2012). 
There are over 600 carotenoids in nature, of which 30-50 are contained in a typical human 
diet and there is uptake of 10-15 of these into the serum. Only L, Z and MZ are present in the 
human retina and the central retina has the highest concentration of carotenoids anywhere 
in the body (Ermakov et al., 2001). The sole source of L and Z is from the diet as, in common 
with all carotenoids, the human body is unable to synthesise them. MZ is produced in the 
retina from dietary L, not being found in serum (Bone et al., 1993) although 
supplementation with MZ leads to detectable increases in serum and retinal concentrations  
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and MPOD (Bone et al., 2007; Connolly et al., 2010). It is debated whether the sole source of 
MZ is from conversion from L within the retina or not (Nolan et al., 2013). 
 It has been shown that concentrations of MP in the retina are associated with seru m 
concentrations of the specific carotenoids and that supplementation with high levels of L 
and Z can increase the concentrations of pigment in the retina (Berendschot et al., 2000) 
There is a time lag between both introduction and withdrawal of supplements and MPOD 
changes (Landrum et al., 1997) although it is debated how long this is with responses to 
supplementation in as little as two weeks reported (Connolly et al., 2010). 
 In dietary terms, L and Z are high in concentration in green leafy plants, egg yolk, yellow 
foods such as corn and other sources such as spices and pistachio nuts (Sommerburg et al., 
1998) (see table 1.1) with eggs being a particularly good source due to the fat content which 
assists bioavailability (Chung et al., 2004). Chickens fed on corn or L/Z enriched feed produce 
eggs high in L and Z which give them their characteristic colour desired by food producers  
and consumers. Free range chickens produce eggs with a higher lutein content than caged 
chickens (Schlatterer and Breithaupt, 2006) and commercially the macular pigments are 
often extracted from marigolds (Bosma et al., 2003). However these carotenoids are not 
popular as a food colouring due to its poor stability when exposed to light (Mortensen and 
Skibsted, 1997), a key property of interest in this study (Haila et al., 1996). Some eye 
targeted or AREDS based supplement manufacturers instead of listing L or Z  label their 
products as containing marigold extract to appeal to the popular naturalistic health fallacy 
whereby products are assumed to be beneficial purely by virtue of being natural .   
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Table 1.1: Major carotenoids in fruits and vegetables in mole %, sorted by lutein/zeaxanthin 
combined content. From (Sommerburg et al., 1998) 
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The uptake of L and Z from the diet is through the small intestine whereupon it is 
transported by lipoproteins in the bloodstream (figure 1.6). The pigments are transported in 
the blood bound to HDL cholesterol as they are hydrophilic and travel to the choriocapillaris 
to be taken up by the RPE. There is a 10000 fold higher concentration of L and Z in the retina 
compared to the blood which indicates that there is a regulated active transport mechanism 
in place to accumulate the pigment, probably by xanthophyll binding proteins, of which 
there are several candidates (Bhosale et al., 2004; Li et al., 2010).  
Retinal tubulin has been found to have a high affinity for carotenoids and likely acts as a 
binding site for L and Z taken up by the binding proteins in the Henle fibres where, like L and 
Z, it is highly concentrated. It is unlikely to be responsible for uptake itself due to its non-
selective affinity for other carotenoids and the absence of those carotenoids in the retinal 
tissue. It has been speculated that some of the greater risk of AMD seen in those with low 
MPOD may be due to low levels of basement membrane bound transport proteins (Li et al., 
2010). This may be an explanation for the existence of people for whom dietary 
supplementation does not increase the MPOD in the retina (Tanito et al., 2012). 
 Dietary supplementation of L Z and MZ appears to be safe, with no significant health effects 
detected (Alves-Rodrigues and Shao, 2004; Bartlett and Eperjesi, 2005; Connolly et al., 
2011). There is some recent evidence of a relationship between MP and glaucoma (Igras et 
al., 2013) which indicates a possible neuroprotective role for MP or that glaucomatous eyes 
either have a lower ability to transport or deposit MP or increased oxidation destroys MP. 
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Figure 1.6: Possible pathway for MP 
carotenoid uptake, transport, and 
accumulation in the human retina. 
Choroicapillaris (CH); Bruch's membrane 
(BM); retinal pigment epithelium (RPE); 
inner segments (IS); outer plexiform 
layer (OPL); inner plexiform layer (IPL); 
selective binding proteins (StARD and 
GSTP1); HDL receptors (SR-BI) .From Li et 
al (2010).  
 
Serum concentrations of L and Z are relatively poor indicators of MPOD and about half of the 
variability in pigment can be attributed to differences in diet and only a third to differences 
in serum concentrations (Bone et al., 2000). The remaining difference may be due to 
differences in uptake; differences in decay rates of the MP due to light exposure or other 
oxidative stress which degrades the MP; differences in transport protein levels or differences 
in macular architecture. 
There are some gender differences in MPOD which are thought to be due to differences in 
the uptake mechanism from serum into the RPE. Males have MPOD levels which are on 
average higher than females and there is a stronger correlation between serum levels and 
MPOD in males. This may partly account for the higher rate of AMD in females (Beatty et al., 
1999). 
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There appears to be some racial differences in MPOD with Blacks having lower levels of 
MPOD than Whites (Iannaccone et al., 2007). This is despite African Americans having almost 
double the dietary intake of L than White and Hispanic Americans and having higher serum 
concentrations of these pigments as a result (Mares-Perlman et al., 2001).   
AMD risk and melanin levels have been found in some studies to be generally inversely 
correlated (Weiter et al., 1985). Racial differences correlate poorly with dietary intake 
indicating there may be differences in MP uptake rates.  Melanin may provide a protective 
role (Hammond et al., 1996), however, the absorption profile of melanin correlates poorly 
with the wavelengths implicated in macular degeneration, indicating that the primary 
protective role of melanin might be as a ‘sink’ for Reactive Oxygen Species  (ROS) rather than 
purely photoprotective.  
 These differences in MPOD observed between races are likely due to genetic differences, 
possibly influenced by geographical differences in light levels encountered through 
evolutionary history (Friedman et al., 1999) although the recent finding that MPOD has also 
recently been found to be higher in South Asians than Whites (Howells et al., 2013a) 
contradicts this hypothesis. 
In general, those with darker irises in a single geographical area tend to have greater levels 
of macular pigment, which could be linked to lower light exposure to the retina due to 
greater iris pigmentation (Hammond and Caruso–Avery, 2000).  
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1.2: Methods of MPOD measurement  
It is desirable, given the importance of MP and its supposed role in protecting the eye from 
several factors leading to the development of macular degeneration, to be able to measure 
MPOD in vivo for both research and clinical purposes. In a clinical setting it can be helpful to 
identify which patients are at increased risk of macular degeneration and to be able to 
assess the effect or otherwise of any supplementation or protective measures such as light 
filtration. Many practitioners, with reference to recent research in the area, recommend 
their patients to take supplements which contain L and Z, often combined with an 
antioxidant formulation based on the AREDS and AREDS2 research (Bartlett and Eperjesi, 
2004a; Kassoff et al., 2001) and many patients with AMD are aware of the research 
surrounding this area and take supplements (Bartlett and Eperjesi, 2004b). These 
supplements are expensive at a recommended retail price of between £9-£15/month and 
being able to confirm that the supplementation levels is having the desired effect on MPOD 
and being able to differentiate which patients are likely to benefit from them is a useful tool.  
From a research perspective, there are many gaps in the current knowledge of the exact role 
MP has in the development of AMD. There are reliable invasive methods of measuring MP in 
the retina such as chromatography, but these are not of use in determining the status of 
living tissue where MP levels cannot be directly measured and must therefore be inferred by 
measuring MPOD. The technique used in this study is heterochromatic flicker photometry 
and this will be described. As other studies referenced have used different techniques to 
measure MPOD, a brief description of alternative techniques for measuring MPOD and 
reasons for the selection of this technique over others  will be provided. Measurements of 
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MPOD can be principally categorised into psychophysical and optical methods. A detailed 
review of the various methods has recently been produced by Howells et al. (2011). 
 
1.2.1: Resonance Raman measurement: 
This optical method illuminates the macula with a low-power argon laser spot and measures 
Raman backscattered light using a spectrograph. The Raman signal intensity at 1525 cm−1 
generated by the carbon–carbon double-bond vibrations of lutein and zeaxanthin can be 
used to quantify the levels of these carotenoids in the retina (figure 1.7). One study using 
this technique failed to demonstrate a difference between levels of MP in those who had 
undergone cataract surgery although it is acknowledged that there is a drop in signal in 
those with age related lens yellowing which may confound results, (Ermakov et al., 2001). 
There are no commercially available instruments. This technique requires  a correction to 
compensate for ocular media absorption which makes it unsuitable for use in this particular 
study (Delori et al., 2001). A more recent study discussed in more detail later which used 
results pre and post operatively to calibrate the correction required to compensate for lens 
yellowing has demonstrated a drop in MPOD 1-2 years after surgery (Obana et al., 2011).  
The technique is controversial, with questions over its repeatability raised (Howells et al., 
2012) 
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Figure 1.7: A map of MPOD produced by 
resonance Raman spectroscopy. From 
(Sharifzadeh et al., 2008) 
 
 
 
 
 
 
 
1.2.2: Reflectometry: 
An established technique which has been used for 25 years, reflectometry analyses the 
spectral reflectance of the retina to provide estimates of MP (Kilbride et al., 1989). There are 
several variations on the method which use both subjective colour matching and objective 
analysis of light reflected from different points on the fundus which will differ as the light 
reflected from areas with high levels of MP will have certain wavelengths attenuated by 
absorption of them by the MP. There are commercial instruments available such as the 
macular pigment reflectometer (MPR, Maastricht instruments, Maastricht, Netherlands) and 
it provides a reliable measurement of MP which is comparable to other methods 
(Berendschot et al., 2000; Delori et al., 2001). There is limited information on the reliability 
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of this method in the presence of cataract and the instruments make assumptions regarding 
the homogeneity of the ocular media which it is reasonable to suppose might be violated in 
cases of cortical cataract in particular and the measurements are known to be impaired by 
light scatter. The technique usually requires pupil dilation  and due to the complexity of the 
optics involved the instruments tend to be rather expensive (Howells et al., 2011). It requires 
bleaching of the photoreceptors before measurements are taken to prevent absorption of 
light by the photoreceptor pigments confounding the results, which requires levels of light 
patients may find unpleasant.   
1.2.3: Fundus autofluorescence: 
This optical technique uses the attenuation of lipofuscin fluorescence originating from the 
retinal pigment epithelium to estimate MPOD. The retina is illuminated using two sources of 
monochromatic light, one of which stimulates fluorescence from MP and lipofuscin together 
and the other which stimulates lipofuscin alone. The spectrum of light reflected from the 
retina can then be used to infer MP levels (figure 1.8). First described in 2001 (Delori et al., 
2001) it has been used in research settings but no commercial instruments are available. A 
similar technique using only one wavelength of light is used by the Visucam device (Zeiss 
Meditec, Jena, Germany) however this makes the assumption that the fluorophores are 
evenly distributed over the area analysed, which may not be the case and is not therefore as 
reliable a method as the two wavelength technique (Dennison et al., 2013; Trieschmann et 
al., 2006). Recent research casts doubt on its ability to reliably measure MP in the presence 
of cataract (Sasamoto et al., 2011)  
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Figure 1.8: Fundus autofluorescence measurement of MPOD in two different eyes. The 
yellow line is the MPOD, the blue and green the aoutoflurescence signal at 488 and 514nm. 
From (Waldstein et al., 2012) 
1.2.4: Heterochromatic flicker photometry: 
The most popular technique for measuring MPOD in practice and widely used in research, 
heterochromatic flicker photometry (HFP) is a psychophysical subjective technique which 
uses the absorption properties of MP and its effect on the visibility of different wavelengths 
of light. This technique has been shown to be reliable in older patients such as those likely to 
be eligible for this research (Snodderly et al., 2004). Two alternating stimuli are presented, 
the wavelength of one stimuli being absorbed by and therefore having reduced visibility in 
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the presence of MP and the other stimulus not being affected by the presence of MP. Where 
the perceived luminance is unequal, the stimulus will appear to flicker and where the 
perceived luminance is equal, the stimuli will appear to be static. The point at which the 
stimulus appears to be steady will depend on the MPOD in the region of the retina being 
stimulated by the test and a measure of MPOD can be inferred from this point. This point 
will be affected by outside factors such as the absorption spectra of the crystalline lens 
which will vary between subjects; therefore a single measurement at the fovea will not 
produce a particularly reliable result. To correct for this typically a measurement is taken 
from the fovea and compared to a measurement taken in the peripheral macula where 
MPOD is known to be low, and the ratio of the two measurements can be used to calculate 
MPOD.  
One potential source of error i n patients supplementing with high doses of L, Z and MZ is 
that peripheral deposition of the MP where it is assumed by the instrument to be close to 
zero may affect the validity of the results (Howells et al., 2011). An estimate of the effect of 
lens yellowing based on age can also be used and although this is prone to error as that 
assumption may not be correct it can still give useful results in patients who are unable to 
complete the peripheral test. It may be adequate in patients where a change in MPOD is the 
outcome to be measured, rather than the absolute value. In subjects with a clear IOL the 
software in the instrument can account for this and assume lens yellowing to be zero. 
There are several methods used to present the stimulus to the patient, the most common 
being a method where the subject adjusts the ratio of the two stimuli until the perception of 
flicker is minimised, and another where the two stimulus are automatica lly alternated at 
progressively lower frequency until the perception of flicker appears. There are commercial 
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instruments available for both methods, the Macuscope and the MPS II. A recent 
comparison of the two instruments in a clinical setting similar to the conditions used in this 
research found that the MPS II gave a more reliable result of the two (Bartlett et al., 2010a, 
2010b) and it is this instrument which has been chosen. 
The MPS 9000, also known as the M|POD, Quantifeye and most recently MPS II, instrument 
(Topcon Great Britain Ltd. Kennet Side, Bone Lane, Newbury Berkshire United Kingdom RG14 
5PX) is described in detail by Van Der Veen et al., (2009) it will hereafter be referred to as 
the MPS (figure 1.9). The repeatability of the instrument has been measured to be between 
0.33 (Bartlett et al., 2010b) and 0.08 (Howells et al., 2013b) by the same research group with 
others falling inside this range (de Kinkelder et al., 2011; Loughman et al., 2012; Makridaki et 
al., 2009; Van Der Veen et al., 2009) The improvements in repeatability made by Howells et 
al were largely made by either removing unreliable data from analysis altogether and 
repeating the test or by subtle adjustment of data to reduce ambiguous results where there 
are two or three possible minima close together as well as the recommendation  that for 
best results the two curves should both be taken twice  
Figure 1.9: The MPS instrument. From 
www.topcon-medical.co.uk 
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The instrument has been shown to give consistent results when confronted with simulated 
age related lens yellowing (Makridaki et al., 2009) which is important for this study which 
assumes the instrument will produce the same reading in phakic and pseudophakic subjects . 
The technique of flicker photometry has been used in two studies which tested subjects 
before and after removal of their cataract, in timescales in which MPOD is unlikely to have 
significantly altered. It was found in both that MPOD values before and after cataract 
removal were not significantly different (Ciulla et al., 2001; Nolan et al., 2009). These results 
indicate that in both a clinical and research setting, this technique and specifically this 
instrument can produce results in untrained observers which are reliable enough to achieve 
the aims of this study. 
 
1.3: Description of the disease process leading to age-related macular degeneration 
AMD is already the most common cause of blindness in the developed world and is likely to 
increase in prevalence as populations age (Congdon NG, 2003). It is a progressive but 
ultimately self-limiting condition which affects the macula region of the eye. These changes 
do not affect the peripheral retina probably due to differences in metabolism between the 
retinal regions (Holz, 1994) although in certain situations widespread haemorrhaging and 
scarring could conceivably cause complete loss of vision to the affected eye.  
The precise aetiology of AMD is not fully understood but appears to multifactorial  (Ambati et 
al., 2003). AMD is characterised by dysfunction of the RPE which usually takes the form of 
pigmentary changes or atrophy in the RPE and lipid rich deposits called drusen (figure 1.10) 
which appear between Bruch’s membrane and the RPE and within Bruch’s membrane. 
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Drusen are preceded by basal laminar and basal linear deposits within bruch's membrane  
(Loffler and Lee, 1986) and do not form randomly - they are more likely to form above the 
'pillars of choriocapillaris'. Though the significance of this finding is currently uncertain it 
may be due to the reduced clearing abilities of the retina of debris in these regions (Lengyel 
et al., 2004).  Focal hyperpigmentation of the RPE also often accompanies drusen and is 
associated with a greater risk of vision loss (Beatty et al., 2001; Wang , 2003).  
 
Figure 1.10: dry macular degeneration with drusen and central RPE atrophy 
The mechanism leading to the formation of drusen is thought to involve oxidative damage 
and ischemia to the RPE and dysfunction of the normal mechanisms which remove cellular 
waste and debris. Metabolic changes lead to incomplete phagocytosis of the photoreceptor 
outer segments as well as the build-up of material which the RPE is unable to remove. The 
drusen and primary aging changes in Bruch’s membrane (Pauleikhoff et al., 1990) are 
thought to interfere with the transfer of oxygen and nutrients between the RPE and the 
choroid, along with other factors such as vitreoretinal adhesion (Stefánsson et al., 2011; 
Weber-Krause and Eckardt, 1996). This often progresses to atrophy of the RPE (figure 1.10) 
and consequent destruction of the photoreceptors which have their outer segments 
embedded into it. Oxidative stress, hypoxia, light exposure and inflammatory processes all 
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thought to contribute to the level and rate of deterioration (Algvere et al., 2006; Bressler, 
2009; Feigl, 2009).  
The RPE cells are either incapable of mitosis (Fleming et al., 1996) or divide very slowly (Al-
Hussaini et al., 2008) and therefore do not significantly regenerate so any damage is 
permanent. Drusen can be dynamic - large drusen when monitored with OCT can sometimes 
be seen to spontaneously regress, although these areas which initially appear to show 
improvement often, but not always, subsequently undergo atrophic changes (Dietzel et al., 
2013; Yehoshua et al., 2011) (figures 1.11, 1.12). 
The visual outcome of dry AMD is dependent on both the location and extent of the damage 
as a small area of foveal atrophy can create more difficulty with everyday tasks than 
widespread geographic atrophy with foveal sparing, although this creates difficulties of its 
own, particularly as the nature of the vision loss is not always apparent to the patient and 
magnification can be unhelpful (Sunness et al., 2008; Wolffsohn and Eperjesi, 2005).  
Early age related maculopathy (ARM) is defined by Bird et al as “soft drusen ≥63μm, 
hyperpigmentation and/or hypopigmentation of the retinal pigment epithelium (RPE), RPE 
and associated neurosensory detachment, (peri)retinal haemorrhages, geographic atrophy 
of the RPE, or (peri)retinal fibrous scarring in the absence of other retinal (vascular) 
disorders.” (Bird et al., 1995b). When more advanced, these changes are classified as late 
ARM and this includes AMD. Dry ARM can sometimes, particularly with ‘soft’ large, ill-
defined drusen, lead to neovascularisation of the retina or choroid from the choroidal blood 
vessels (Freund et al., 2008). 
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Figure 1.11: Spontaneous drusen regression in a 64 year old woman over 6 months without 
progression to advanced AMD. From (Yehoshua et al., 2011) 
 
Figure 1.12: Drusen progressing to geographic atrophy involving the fovea over 6 months: 
from (Yehoshua et al., 2011) 
Drusen number, size and confluence are significant risk factors for progression to advanced 
AMD (Pauleikhoff et al., 1990; Sarks, 1980). Soft drusen are also associated with a higher risk 
of advanced dry disease (Pollack et al., 1996; Wang, 2003). It is thought that in the disease 
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process leading to neovascular ‘wet’ AMD the damaged RPE alters the balance of the 
hormones it produces, specifically vascular endothelial growth factor (VEGF), which 
encourages vascular proliferation, and pigment epithelium-derived factor (PEDF), which 
suppresses it (Bhutto et al., 2006).  
Increased VEGF and decreased PEDF lead to vascular budding and proliferation of vessels 
which penetrate Bruch’s membrane and typically leak fluid into the retina  (figure 1.13), 
causing a characteristic symptom of distortion of the central vision. The vessels if untreated 
usually  then haemorrhage and cause widespread scarring and rapid loss of central vision 
although sometimes neovascular membranes spontaneously regress (Freund et al., 2008). 
Fortunately, new drugs known as anti-VEGF agents such as Lucentis (Ranibizumab) and 
Avastin (Bevacizumab) when injected into the eye can supress and reverse this 
development. 
 
Figure 1.13: Neovascular (‘wet’) AMD  
After treatment, vision often improves to the levels allowed by existing dry changes 
(Loughman, 2013) which will usually continue to progress, albeit often slowly. It is thought 
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that in the absence of excess VEGF, PEDF causes regression of the neovascular membrane 
(Mori et al., 2002). These treatments, unlike laser and photodynamic therapy, are useful for 
lesions involving the fovea which were previously difficult to treat (Bakri and Kaiser, 2004). 
Dry macular changes and the geographic atrophy that they tend to lead to given sufficient 
time are currently incurable. There are several suggested treatment modes involving 
regeneration of the RPE through stem cell injection; gentle laser treatment of drusen (Ho et 
al., 1999); transplantation of healthy RPE from the periphery to the macula (Peyman et al., 
1991); translocation of the retina (Lai et al., 2002) and implantation of photosensitive CCD 
chips into the retina to replace the damaged tissue (Ahuja and Behrend, 2013). As yet none 
of these methods are sufficiently developed to restore any significant sight to the eye with 
advanced AMD. Current interest therefore is focussed not only on treatment but also on the 
cause of AMD and possible mitigation of those causes 
There are several known modifiable risk factors for AMD, the principal ones being age, diet, 
sunlight exposure, alcohol use, vascular health, exercise and smoking (Thornton et al., 2005). 
These all contribute to the ischemia and oxidative damage experienced by the RPE due to 
the high levels of metabolism and the free radicals produced by exposure to light, 
particularly blue light  in the presence of high oxygen concentrations such as those found at 
the macula (Ruffolo Jr. et al., 1984), the increased production of oxygen free radicals caused 
by incomplete metabolism in chronic ischemia and in the presence of lipofuscin (Dorey et al., 
1989). 
Lipofuscin is electron rich autofluorescent membrane bound cellular waste composed of free 
radical damaged protein and fat. It results from the incomplete breakdown of waste such as 
used photoreceptor segments which cells cannot remove. In the case of non-dividing cells 
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such as the RPE lipofuscin accumulates with age (figure 1.14).  It has been implicated in a 
wide range of neurological disorders as well as AMD (Family et al., 2011; Schraermeyer and 
Heimann, 1999). It is not yet clear whether lipofuscin accumulates continuously over an  
individual’s lifetime or whether it only starts to accumulate as the RPE ages. Lipofuscin is 
photoreactive at the same wavelengths which cause maximum damage to the RPE (Margrain 
et al., 2004). This implies that reducing the exposure of the retina to light and improving the 
ability of the retina to deal with the by-products of metabolism may help preserve the health 
of the RPE and delay the onset of AMD.  
The defence mechanisms of the retina against oxidative damage are known to decline with 
age (Boulton et al., 2001). However, the precise mechanism of damage is not well 
understood and it is unclear under what timescale modifying the risk factors is likely to be 
most effective. For example, much of the light exposure from the blue and UV end of the 
spectrum that the retina receives is in the first few years of life implying that childhood 
control of light exposure may delay AMD development. Conversely,  due to the action of 
increasing lipofuscin with age the effect that blue light has on the retina actually increases 
with age, implying that reducing light exposure has a greater effect with advancing age 
(Margrain et al., 2004; Simons, 1993). Unfortunately, partly due to the weakness of 
epidemiological studies in determining light exposure over lifetimes through subjective 
questionnaires, it is not clear which of these aspects is the more important (Klein et al., 
2004).   
This lipofuscin mediated damage may explain why antioxidants delay AMD progression 
(Kassoff et al., 2001). Lipofuscin produces reactive oxygen species (ROS) when exposed to 
light as well as physically affecting the internal workings of the RPE cells through congestion. 
46 
 
Further evidence for the theory of lipofuscin mediated damage comes from the fact that 
lipofuscin and drusen are spatially correlated (Delori et al., 2000). Racial differences in 
lipofuscin mirror AMD risk, with RPE lipofuscin accumulation being greater in whites. 
Although the RPE melanin content is similar between racial groups, the choroidal melanin 
content is greater in dark skinned individuals (Weiter et al., 1986). 
Figure 1.14: Lipofuscin (L) granules in the RPE cell of a 70 year old woman. Marked with an 
arrow are melano-lipofuscin granules, which contain a core of melanin. From (Schraermeyer 
and Heimann, 1999) 
As the crystalline lens ages, it gradually reduces the intensity of light exposure to the retina, 
particularly blue wavelengths (Figure 1.15), probably protecting the retina from earlier 
damage. Early removal of cataracts, as is now becoming more widespread through the use 
of clear lens extraction as a procedure to correct refractive error, presbyopia (Alfonso et al., 
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2010) or angle closure (Rathi et al., 2011) and also as a consequence of the procedure to 
remove them being less risky, changing the risk/benefit ratio, could potentially increase the 
risk of AMD in these individuals. However, it should be borne in mind that left untreated 
cataract causes greater levels of vision loss than AMD (Cook and Stulting, 1995). 
 
Figure 1.15: The transmission of different colours through the human lens as it ages. From 
(Kessel et al., 2010) 
There is evidence that AMD progresses faster in eyes which have had the cataracts removed 
(Pollack et al., 1996; Schaft et al., 1994) although the evidence is not conclusive (Chew et al., 
2009; West, 1989) the Beaver dam study showed an association between cataract removal 
and late, but not early AMD (Klein et al., 2012).  A recent meta-analysis concluded that 
cataract surgery is a strong risk factor for AMD comparable to smoking (Chakravarthy et al., 
2010).  There is evidence of several non-modifiable risk factors apart from age with studies 
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showing that the predisposition to AMD has both genetic as well as environmental aspects 
(Meyers, 1994; Silvestri et al., 1994).  
1.4: Implications of MPOD for macular degeneration 
MP is thought to have a dual protective role against the development of AMD with both 
barrier and antioxidant action. It is therefore thought that pigment levels may influence the 
risk of AMD, and there is growing evidence that this is the case (Sabour-Pickett et al., 2012). 
A recent meta-analysis found that those with increased intake of L and Z had a lower risk of 
late AMD, although the association between early AMD and L/Z intake was not statistically 
significant (Ma et al., 2012). The xanthophylls may also protect against cataract (Delcourt et 
al., 2006) although preliminary results of the AREDS2 study did not find any effect (The Age-
Related Eye Disease Study 2 (AREDS2) Research Group, 2013). 
Low MPOD has been found to correlate with a higher risk of AMD in several studies (Sabour-
Pickett et al., 2012) although the association appears to be complex, as many risk factors for 
AMD are associated with lower MPOD (Nolan et al., 2010, 2007) complicating the 
cause/effect relationship between the two variables. There is some evidence that MP and 
antioxidant supplementation increases VA in patients with AMD  (Richer et al., 2004; 
Weigert et al., 2011). However the effect is mild and requires further study with other 
studies not finding an effect (Bartlett and Eperjesi, 2007). It is unclear whether the effect 
these studies have found is due to an improvement in function or a reduction of light scatter 
as has been demonstrated in normal eyes (Weigert et al., 2011). Improvements in contrast 
sensitivity have also been reported in normal subjects who supplement with L and Z (Nolan 
et al., 2011). 
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 A recent study in mice showed that those supplemented with lutein had significantly lower 
levels of light induced photoreceptor apoptosis and DNA damage than those fed a normal 
diet (Sasaki et al., 2012) although caution should be applied when extrapolating the results 
of animal experiments to humans.  
Provisional results of the AREDS2 study suggest that L and Z supplementation provides 
significantly greater benefit than the original AREDS supplement in individuals who have a 
low dietary intake of carotenoids. The same results also imply that replacing beta carotene 
with L and Z increases the protective effect mildly (The Age-Related Eye Disease Study 2 
(AREDS2) Research Group, 2013) whilst making the supplement safe for smokers, who are at 
a significantly increased risk of AMD. Beta-carotene significantly increases the risk of lung 
cancer in smokers and ex-smokers (Tanvetyanon and Bepler, 2008). 
It appears therefore that factors which reduce MPOD also increase the risk of AMD. This is 
thought to occur through a lack of barrier protection from blue light and the increased 
oxidative damage associated with both an increase in light levels generating free radical 
species and impaired neutralisation of those free radicals due to the absence of the 
antioxidant properties of MP (Kijlstra et al., 2012). ROS generation through light exposure is 
lower in the retinas of mice fed lutein than those that were not (Sasaki et al., 2012). It is 
thought that light exposure to the retina, particularly blue light, increases the risk of AMD 
through these effects. Certainly acute light exposure can damage the retina  (Michels and 
Sternberg Jr., 1990) but remains to be proven whether chronic exposure to sunlight causes 
AMD (Sui et al., 2013). 
Blue light has been shown to have significant impacts on photoreceptor and RPE health 
(Algvere et al., 2006). Light of shorter wavelengths than 300nm are absorbed in adults by the 
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cornea and between 300-400 by the lens (Margrain et al., 2004) which makes it unlikely that 
these wavelengths are responsible for significant retinal damage.  Increasing MPOD and 
reducing visible light exposure, particularly at the blue end of the spectrum, may therefore 
reduce the risk of  AMD and the most significant factor determining blue light exposure to 
the retina in the elderly is probably cataract due to the absorbance of blue light by the lens 
(Charman, 2003). 
 
1.5: The natural course of cataract and the effect on retinal light exposure 
Cataract is the gradual increase in opacity in the crystalline lens which sits behind the iris, 
suspended from the cilliary muscle by fibres called zonules (Michael and Bron, 2011). It is a 
gradual process which occurs in all people from birth although usually only becomes visually 
significant in the elderly with the exception of congenital and secondary cataracts. 
The crystalline lens is made up of millions of fibres which are arranged with small articulating 
joints in between which gives the lens flexibility. Its transparency is due to regular 
arrangement and structure to the fibres which decreases with age, causing back scatter and 
decreasing transmittance (Trokel, 1962). Cataract is primarily classified as nuclear, involving 
the centre of the lens, and cortical, involving the outer layers. It is nuclear cataract which is 
largely responsible for the gradual changes in overall light transmittance and the changing 
spectrum of transmitted light through the lens with age (Lerman et al., 1978).  
 The development of nuclear cataract is also linked to oxidation (Truscott, 2005). The earliest 
sign of the aging changes in the lens that most people notice is the onset of presbyopia, in 
which the loss of structural uniformity in the lens affects its ability to change shape and 
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focus (Glasser and Campbell, 1998) and this may be considered a stage of nuclear cataract 
development (McGinty and Truscott, 2006). Around the age of 45, this usually affects the 
ability of the eye to focus to the point where it becomes necessary for most to wear reading 
spectacles, although as with the transparency of the lens this process has been occurring 
gradually since childhood with a gradual loss of accommodative ability. The optical density of 
the lens increases with age (Hammond et al., 1997) but the transparency of the lens does 
not affect all wavelengths uniformly. By the late teens, almost all UV is blocked before it 
reaches the retina (Lerman and Borkman, 1976), and by the age of 60 only 20% of blue light 
incident on the eye reaches the retina largely due to loss of lens transparency (Mellerio, 
1987). This change is due to the deposition of pigments known as chromophores into the 
lens which block short wavelength light (Dillon et al., 1990). 
Senile miosis also reduces the level of light reaching the retina but the effect is minor 
compared to that of the lens (Sample et al., 1988). The rapid development of dense cataract 
can be distinct from the gradual aging changes, often accompanied with a rapid myopic shift 
as the refractive index of the nucleus increases, in contrast to the slow hypermetropic shift 
experienced with age by most individuals as the refractive index of the lens decreases 
(Brown and Hill, 1987; Dubbelman and Van der Heijde, 2001) . This myopic shift is not 
associated with cortical or posterior subcapsular cataract (Brown and Hill, 1987).   
Cortical cataract is associated with UVB exposure (Taylor, 1999) and it may be that age 
related changes in the lens permit further oxidation of the nucleus through sensitisation of 
the lens proteins to UV related to ageing (Linetsky et al., 1996) causing an acceleration of the 
changes which lead to cataract. There appears to be a positive feedback process whereby 
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aging changes in the lens inhibit the diffusion of antioxidants into the lens nucleus, further 
damaging the lens (McGinty and Truscott, 2006). 
Most Intra-ocular lens (IOL) implants are transparent to all visible light, leading many 
cataract patients to notice changes in their colour perception - the artist Monet is a well-
known example of both the effect that cataract and the changes in colour perception upon 
their subsequent removal have on the patient (Ravin, 1985). These changes eventually 
renormalize, but not fully (Delahunt et al., 2004).  
There is some disagreement as to whether IOLs should be blue blocking or not (Mainster, 
2005) due to the potential effects on night vision due to the reduction in light transmission 
compared to a clear IOL and the trade off with the theoretical protecti on against AMD 
(Cuthbertson et al., 2009). Other proposed disadvantages to blue blocking IOLs include 
disturbance of the circadian rhythm and a reduction in scotopic vision but due to the 
transmission properties of blue blocking IOLs compared to a normal crystalline lens  (figure 
1.16), these concerns are probably unfounded (Blackmore-Wright and Eperjesi, 2012; 
Davison et al., 2011). 
Yellow filters improve contrast but also mildly affect colour vision (Wolffsohn et al., 2000)  
although obviously cataract also has detrimental effects on colour perception in the people 
being considered. A recent study found no difference in colour vision between the eyes of 
people implanted with a blue blocking lens in one eye and a clear lens in the other (Kara-
Junior et al., 2011). They do not appear to be in routine use in the NHS, probably due to cost. 
Only three patients have blue blocking IOLs in the practice from which the subjects for this 
study were selected. These are noticeable under slit lamp examination due to the yellow tint  
(figure 1.17)  
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Figure 1.16: comparison of the transmission spectrum of natural and artificial lenses: Blue 
light filtering models are represented by the red and green lines and clear IOLs by the yellow 
and orange. From (Romano et al., 2011) 
 
Figure 1.17: Blue blocking IOL viewed with slit lamp showing visible yellow tint.  
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It has long been known that sunlight damages cells, particularly those of the skin and RPE 
(Wang, 1975) and blue light has been found to be 30 times more efficient at inducing 
damage to the RPE than yellow light (van Best et al., 1997). Light induces cell apoptosis 
(often referred to as programmed cell death). It is thought that the increased exposure that 
results from cataract removal may, by increasing the light exposure to the retina, cause 
increased rates of cell death and AMD severity and that increased MPOD may reduce this 
level of damage. 
1.6: MPOD and the effect of light exposure 
Lutein and zeaxanthin are known to photobleach, that is to degrade in the presence of light 
(Mortensen and Skibsted, 1997), although more slowly than some other carotenoids which 
may be an explanation for their selective uptake into the retina (Siems et al., 1999). It has 
been shown that blue light filters slow cell apoptos is in vitro both without (Kernt et al., 2012; 
Rezai et al., 2008) and with (Sparrow et al., 2004) the presence of the light sensitive oxidisers 
lipofuscin and N-retinylidene-N-retinylethanolamine (A2E), a lipofuscin fluorophore.  
Of interest to this study is the effect that light exposure has on the MPOD in vivo. Some 
studies have shown no association (Khan et al., 2006) although studies which attempt to 
evaluate historical light exposure between individuals are fraught with confounding factors 
which cast doubt on the validity of the results. It has, as would be expected, been shown by 
experimentation that MP is degraded in vitro and requires constant replacement 
(Lakshminarayana et al., 2008)  and it is likely that light exposure plays a part in this process 
in vivo, as has been proven to occur in vitro 
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It has been shown in one study that MPOD increases after implantation of blue blocking IOLs 
(Nolan et al., 2009). This result is not what would be expected if the MP levels are 
determined by a simple equilibrium between oxidation and photobleaching versus uptake. 
As usually the cataract would be already acting as a blue filter and the lenses used have a 
transmission spectrum similar to the average 50 year old human lens (Obana et al., 2011), 
the light exposure to the retina following implantation of a blue blocking IOL would almost 
certainly be greater than the exposure before the operation. 
 This may suggest that the blue blocking IOL is a more effective filter than the cataract which 
was removed, which would seem unlikely; that there is a more complex relationship 
between light exposure and MPOD than previously thought; or that there was some degree 
of bias not controlled for such as differences in light aversion behaviour between the groups . 
This same study did not show that in the short term (three months) there was any drop in 
MPOD in the group implanted with clear IOLs. 
 Similarly, it has been found that no difference in MPOD was found after one month of being 
implanted with a clear IOL (Ciulla et al., 2001) and one week after (Nolan et al., 2009).  These 
studies used flicker photometry to evaluate MPOD and lend confidence to the consistency of 
results found before and after cataract removal using HFP. 
Another longitudinal study using Raman spectroscopy found that MPOD decreased in all 
subjects given both blue blocking and clear IOLs, but that change was greater in the clear IOL 
group (Obana et al., 2011). The disparity between the two groups did not appear until after 
6 months had passed since the operation which removes the issues described earlier 
regarding the use of a conversion factor to compensate for lens colour with Raman 
spectroscopy. The fact that all eyes displayed reduced MPOD would indicate that blue 
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blocking IOLs do not eliminate the effect of light exposure on MPOD entirely and contradicts  
the absolute, but not the relative effect the earlier Nolan et al 2009 study found which 
showed augmentation of MP. It also does not allow for differences which may occur 
between the two groups in behaviour regarding sunlight exposure as a result of the different 
IOL, for example if the group with blue blocking IOLs were more likely to stay indoors or 
wear sunglasses, this may affect the results, a potential  confounding factor.  
These studies indicate that MPOD is affected by cataract removal, and by implication light 
exposure in vivo, but only after several months to a year. Further study is required to 
confirm this fact, preferably of alternative design. These studies do not resolve the debate 
on there being any significant active regulation of MPOD levels via a feedback mechanism 
such as that proposed by Nolan et al (2009) whereby reduced MPOD or increased light 
exposure increases uptake of L and Z from the bloodstream. The study by Nolan et al 
suggests that such a feedback mechanism exists and is strong enough to match any 
photobleaching caused by the increase in light exposure induced by implantation of a clear 
lens and causes an increase when a blue blocking lens is implanted. The studies by Obana et 
al (2011) and Demirel et al (2013) suggest that either no mechanism exists or it is too slow or 
too weak to overcome the increase in light exposure the retina experiences with either blue 
blocking or clear lenses at least in the duration the studies investigated. The relative effect is 
similar in all the studies. 
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1.7: The structure of the macula and relationship with MPOD 
The normal fovea has a pit like structure when viewed in cross section (figure 1.18) 
 
Figure 1.18: OCT scan of the normal human fovea: from (Marmor, 2008) 
In this area, the transmission of the signal from photoreceptor to ganglion cell is simpler 
than in the rest of the retina, with fewer intermediate neurones between the 
photoreceptors and ganglion cells (Curcio and Allen, 1990). The area is avascular and much 
thinner than the surrounding retina due to the less complex circuitry above. This leads to 
less optical scattering of the light above the most tightly packed photoreceptors, improving 
the vision (Gorrand, 1979). This is an evolutionary adaptation brought about by the 
organisation of the retina with the photoreceptors underneath the neural tissue (Lamb et 
al., 2007). 
 In other creatures where the eye has evolved separately, such as cephalopods, the 
photoreceptors are on the inner surface of the retina (figure 1.19). This organisation brings 
advantages in resolution and the lack of a blind spot but could lead to greater vulnerability 
of the photoreceptors to light damage. The advantages of the ‘correct’ design with the 
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photoreceptors on the inner surface would also eliminate the need for a central avascular 
zone which may be partly responsible for the vulnerability of this region to damage (Novella, 
2008). Only primates, and not all primates, possess a fovea. It is thought to be linked to the 
formation of the foveal avascular zone (FAZ) (Dubis et al. 2012) and other animals have a 
minimally vascularised area centralis, which is a region of more specialised cells at the  centre 
of the retina, or a visual streak, a band of higher resolution receptors (Provis et al., 2013). 
 
Figure 1.19: Anatomical differences between cephalopod and mammalian eyes: From 
(Novella, 2008) 
The simple transmission of the signals at the fovea would appear to serve two functions – 
the elimination of most of the retinal layers leads to less scattering of light and the low 
convergence of photoreceptor to ganglion cell decreases the signal compression compared 
to the rest of the retina in the outer retinal layers, leading to better spatial  resolution in this 
area (Curcio and Allen, 1990). 
This basic model however does vary between individuals, from those with a very deep foveal 
pit to those where it is almost absent (Dubis et al. 2012). Figure 1.20 gives examples of 
foveal pits of differing depth and width  
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1.20a: thicker than average fovea 
1.20b: a thinner than average fovea 
1.20c: a wider than average fovea 
Figure 1.20: Anatomical differences in normal foveal pits  from subjects used in this research. 
In extreme cases, foveal hypoplasia is the almost complete or complete absence of the 
foveal pit, thought to arise from the lack of a FAZ. These cases however can vary greatly in 
visual acuity and are often as a result of conditions which independently impair vision, 
leading to doubt as to how great an effect the lack of the foveal pit itself has on the visual 
acuity (Marmor, 2008). It is likely that the pit itself has only a minor effect on central visual 
function, with the increased cone density being largely responsible for the high central 
acuity (Provis et al., 2013). 
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 Macular pigment deposits across the fovea to about four degrees eccentricity in particularly 
high concentrations in the Henle fibres and inner plexiform layers  (figure 1.21).  The pigment 
is deposited at the fovea in the Henle fibres (figure 1.22) and parafoveally in the axons of the 
inner and outer plexiform layers (Trieschmann et al., 2007). 
Figure 1.21: Two examples for the divergent spatial distribution of the macular pigment in 
the human fovea. The foveal section (a) and parafoveal section with 200 m distance to the 
centre (b) of specimen 1 .The MP with an extension about 600 m is well visible in both 
photographs. In contrast in the case of MP extension of 300 m the MP is visible only in the 
foveal section (c), but not in the parafoveal section in 200 m distance to the centre (d). 
Picture and legend from (Trieschmann et al., 2007) 
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The factors which lead to the density of the deposition of MP are not fully understood. It is 
thought that serum carotenoid levels and differences in membrane transport proteins 
influence the rate of uptake into the retina (Li et al., 2010; Mares-Perlman et al., 2001), but 
it is less clear whether anatomical differences between the retinas of individuals play a part 
in the quantity of MP deposited.  It is also unclear whether early disease processes, such as 
aging changes in the retina, lead to changes in the deposition of MP.  
 
Figure 1.22: Section of the retina showing the Henle fibres, one location where MP is 
deposited (between red arrows) from (Drasdo et al., 2007) 
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1.8: The relationship between MPOD and macular thickness: 
There are several reasons to suppose there might be a relationship between MPOD and 
central foveal thickness. The architecture of the fovea may have an impact on the uptake 
and binding of MP and these structural variations may also manifest themselves as thickness 
differences. The structure of the fovea is organised with a central pit from which many of the 
layers of neurons are absent to allow maximum light transmission and minimal scatter to the 
densely packed cones below. It may be that a shallower foveal pit is capable of retaining 
greater levels of MP due to the greater thickness of the outer plexiform and Henle fibre 
layers where L and Z are bound.  
Another possibility is that there may be structural changes caused by early age related 
structural damage to the retina which predispose to low levels of MP and simultaneously 
reduce foveal thickness. It has been found that that the retina becomes thinner with AMD  
(Richer et al., 2012). Some, but not all, studies have found a general relationship between 
central retinal thickness and age (Chan, 2006; Eriksson and Alm, 2009) which could be due to 
either a general aging process or an increase in the number of individuals with eye diseases 
such as ARM which are known to cause macular thinning.  
Age related thinning may reduce the capacity of the retina to retain MP, thus exposing the 
retina to further damage as part of an on-going disease process. Alternatively, primary loss 
of MP may lead to oxidative damage which causes retinal thinning through apoptosis of 
neurons overlying the photoreceptors in response to oxidative damage or loss of RPE. It is 
known that in patients with macular disease, both MT and MPOD are reduced which could 
be due to a causal relationship either way or comorbidity depending on the disease (Aleman 
et al., 2001; Duncan et al., 2002). 
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Understanding the relationship between MPOD and macular thickness may be important for 
our understanding of the factors which contribute to increased risk of AMD and uptake of 
MP into the retina. Higher resolution OCT should improve the ability to detect subtle 
differences in MT over earlier studies using time domain OCT. The knowledge may also allow 
optometrists who use OCT in practice to identify which patients to screen for low MPOD, or 
identify foveal thinning as a risk factor for AMD before visible changes to the RPE occur.  
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1.9: OCT and cataract 
Optical Coherence Tomography (OCT) is an imaging technology first described in 1991 
(Huang et al., 1991). It is a method of imaging semi-transparent tissues using low coherence 
interferometry to visualise layers of different reflectance. The lens, cornea and retina are 
excellent tissues to image in this way as they are constructed of layers which can easily be 
identified by their differential reflectiveness (Swanson et al., 1993). 
There are two main types of OCT – the older, time domain OCT which uses a moving mirror 
to scan the beam and the newer, spectral domain instruments which use Fourier 
transformation to analyse the interference pattern created between the reference and 
imaging beam without the need for the mirror. This greatly reduces the scan time and 
increases the resolution of the instruments, reducing motion artefacts and the effects of 
media opacities such as cataract (Ho et al., 2009). One of the advantages of OCT in primary 
practice is that it can be used to image the retina in patients with media opacities but in 
whom it is not possible to exclude retinal pathology using conventional methods due to a 
poor view of the fundus (figure 1.23).   
The first use of OCT was to image the posterior segment (Swanson et al., 1993). The central 
retina can be imaged to give novel views of pathology such as macular degeneration, 
epiretinal membranes, macular oedema, macular holes and other retinopathies. It is useful 
to differentiate between conditions which are not always readily distinguishable or even 
visible on retinal photography or slit lamp examination such as vitreo-macular traction and 
mild oedema (Drexler W et al., 2003). The optic nerve can also be imaged to provide 
information about the Retinal Nerve Fibre Layer (RNFL) which is the most sensitive way of 
detecting glaucoma after assessment of stereo photographs by a panel of expert 
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ophthalmologists and more sensitive than the Heidelberg retinal tomograph or GDx laser 
polarimiter instruments  (Azuara-Blanco et al., 2003; Lee et al., 2013; Mwanza et al., 2011). 
 
 
Figure 1.23: Poor retinal image using fundus photography (due to posterior capsular 
opacification) and below the same eye imaged with OCT showing drusen not visible on 
photograph.  
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It can be used to detect pathology through cataract or other media opacities although 
imaging through corneal dystrophies can be difficult due to the high reflectivity of the 
cornea in these conditions. Imaging is possible where these are clear areas of the cornea in 
between the opacities but this requires a co-operative patient who can keep very still.  
A more recent development of OCT technology is its use for anterior segment imaging (Izatt 
et al., 1994). Instruments for this purpose are either dedicated AS-OCT instruments such as 
the Zeiss Visante (Zeiss Meditec, Jana, Germany) or adaptations of instruments primarily 
developed for posterior segment imaging. Dedicated instruments are different in a couple of 
important ways from multi-function OCT instruments – in the wavelength of light used and 
in the field of view which can be obtained.  The Zeiss Visante is a time domain instrument 
which uses a 1300µm wavelength as opposed to the 840µm used by the Cirrus. This 
increases the tissue penetration and allows imaging of structures through the sclera such as 
the ciliary body which are not readily visible in most individuals due to the high reflectivity of 
the sclera to the 840µm wavelength (Hoerauf et al., 1999). This penetration comes at the 
expense of resolution.  Instruments which have variable or wide spectrum light sources are 
likely to overcome the limitations of current instrume nts to some extent. 
 
1.9.1: Using OCT to assess cataract types and similar measurements 
Of interest to this study is the development of cortical cataract, as the principle of using OCT 
to assess nuclear cataract has already been demonstrated, albeit using a different 
instrument, the Zeiss Visante (Wong et al., 2009). Cortical cataract affects the outer layers of 
the lens (the cortex) and tends to progress gradually towards the visual axis from the 
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equator of the lens, although sometimes early cortical defects can occur in isolation along 
the visual axis, commonly to the anterior surface of the lens which receives greater light 
exposure, not being protected by absorption from the nucleus. Several studies have 
associated cortical cataract with light exposure, particularly UV exposure (Bochow, 1989; 
Delcourt C, 2000; Hr et al., 1988) .  
In principle, the use of OCT to provide images of cataract is valid as the OCT gives images 
with easily extractable data on reflectance. It is possible in practice to visualise with OCT 
sections through human lenses – for example, figure 1.20a shows a section through an IOL, 
figure1.20b shows cortical opacities that can be related to lens sections imaged with a slit 
lamp, figure 1.20c shows a lens with mild cortical opacities, 1.20d shows a young lens cortex 
and 1.2e shows the visibly denser cortex of a typical 55 year old.  
Whether this data can be used to reliably grade cortical cataract in a way which gives 
clinically useful results is unknown. The strength of OCT scanning of the lens over slit lamp 
images is the easy access to objective data in contrast to subjective visualisation of cataract 
with a slit lamp. If this data can be shown to accurately reflect the severity of a cataract it 
has many advantages over slit lamp grading as both a research and clinical tool.  
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Figure 1.24: examples of lenses imaged with OCT; 3mm OCT scan through an artificial IOL. 
 
3mm OCT scan through a lens with dense cortical opacities:
 
Lens cross section through an undilated 2.5mm diameter pupil with mild cortical opacities 
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The lens cortex of a 27 year old. 
 
The lens cortex of a 55 year old 
 
It would be an advantage to primary care practitioners to be able to quantitatively assess 
cataract through undilated pupils with a quick, non-invasive technique, using an instrument 
which is widely available. The current referral criteria widely used for NHS referrals are 
based on visual acuity, which although a good measure of whether for example a patient 
meets the required standard for driving, is a poor predictor of cataract density or symptoms 
(Elliott and Situ, 1998).  
There have been attempts to produce vision tests , usually involving lower contrast letters 
than standard logMAR or Snellen charts which more accurately reflect the visual status of 
the patient, with some success (Ni et al., 2012) but none have gained widespread use. 
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 The ability of OCT to give images through lens opacities which seriously degrade the quality 
of a fundus photograph or ophthalmoscopy image means that many of these patients will 
already be being examined on these instruments in practices where they are available. A 
protocol to quickly and objectively record the severity of cataract and perhaps track it over 
time would be an advantage in determining when referral is appropriate.  
The LOCS III grading system is widely used to assess cataract severity for research purposes 
and is based on photographic grading scales of nuclear density, nuclear colour, cortical 
cataract extent and posterior capsular opacification (Chylack et al., 1993) (figure 1.25). It 
requires pupil dilation and careful slit lamp set up to achieve repeatable results and is thus 
inherently time consuming and, with the use of dilating drops, invasive. It is not in common 
usage in routine practice in UK optometric practice or ophthalmology departments to inform 
decisions on whether to refer or operate, with criteria being based on symptoms, VA and 
degree of anisometropia. A more reliable measure of cataract assessment than VA 
measurements could help identify those who most require treatment but do not fall within 
referral criteria. 
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Figure 1.25: The LOCS III grading scale. From (Chylack et al., 1993) 
Despite the potential advantages and clearly applicable principle of using OCT to grade 
cataract little research on the subject seems to exist. There are many papers which mention 
the potential for artefacts to occur when scanning through a cataract to the posterior 
chamber, but only a handful which use the OCT to image the lens, perhaps due to the 
anterior segment capabilities of OCT only recently becoming commonplace. Another limiting 
factor on earlier research may be movement induced artefacts with time domain OCT which 
anterior segment OCT is particularly prone to given the proximity of the anterior chamber to 
the lens through which the scanning beam is focussed (Li et al., 2006). It is almost impossible 
to produce a motion artefact with posterior segment fourier domain OCT, but motion 
artefacts on anterior segment images do still occur (figure 1.26). 
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Figure 1.26: A motion artefact whist scanning the lens cortex.  
OCT images have been compared with histological sections from Rhesus monkeys showing 
faithful tissue imaging, although limited by the technology of the time (DiCarlo et al., 1999) 
and one study has used OCT to compare to LOCS III grades for nuclear cataract (Wong et al., 
2009). This used Visante OCT which uses a wavelength of 1310nm, whereas the instrument 
used in this study, the Cirrus, uses a wavelength of 840nm (figure 1.27).  
 
Figure 1.27: Zeiss Cirrus 4000 OCT (Zeiss Meditec, Jana, Germany)  
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The grading of cortical cataract can present a problem when attempting to correlate 
symptom severity with objective measurements due to its nature. A minor cortical opacity 
that intersects the visual axis can have a much greater effect on vision and symptoms than a 
dense peripheral cortical cataract of large extent that can, particularly in those with senile 
miosis, be hidden behind the pupil and have little if any effect on vision (Chua et al., 2004). 
 A measurement of cortical opacity along the visual axis and within the pupil aperture may 
give a more reliable indicator of symptoms than a measure of the extent of an opacity with a 
dilated pupil which lies largely hidden, as with the LOCS III grading scales or other measures 
using retro illumination – with an undilated pupil however any attempt to gain a slit lamp 
image immediately constricts the pupil to an artificially small area. OCT scanning uses light 
outside the visible range hence it can record an image which accurately represents the 
maximum lens area exposed under normal dark conditions such as those encountered whilst 
driving at night, a task with which those with cortical cataract affecting the visual axis tend 
to find difficulty due to the glare of oncoming headlights. The OCT scanning beam does not 
tend to constrict the pupil significantly under these conditions, particularly when the fixation 
target is carefully focussed for the distance. 
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1.20: Conclusion 
There are gaps in our current understanding of the in vitro behaviour of MP when exposed 
to light, our understanding of how MPOD relates to the physiology of the macular region and 
our ability to objectively grade cortical cataract in a way which accurately reflects the visual 
status or symptoms of the patient. This study will attempt to narrow those gaps by applying 
new techniques and technology to the assessment of MP, macular thickness and the density 
of the lens cortex as detailed in the following chapters. 
The next chapter is a literature review of the evidence pertinent to the experimental 
chapters where previous research will be presented to demonstrate the evidence base for 
the experiments. 
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Chapter Two 
Literature review 
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In the previous introductory chapter the background to AMD, MP, MPOD, the structure of 
the macula and its relationship to MPOD and the possible use of OCT to quantitatively 
measure cataract density has been presented. This chapter with cover the research on which 
the experimental chapters are founded, followed by the rationale for each experiment based 
on the previous research and the gaps in current knowledge. 
 
2.1: Research investigating relationships between light exposure, pseudophakia, MPOD and 
AMD 
Several studies have attempted to associate light exposure and AMD risk and/or MPOD. 
These studies are summarised in detail in table 2.1. They can be divided into in vitro studies, 
animal studies and human studies and all have specific benefits and drawbacks.  
In vitro studies have demonstrated in principle that there are adverse implications for light 
exposure on MPOD and the health of the RPE and photoreceptors; for example 
Lakshminarayana et al. ( 2008); Siems et al. (1999); Sparrow et al. (2004). These studies by 
definition however create an artificial environment and there is always an inherent degree 
of uncertainty as to how applicable the results are to humans in real life situations  as 
complex interactions between variables in a living organism may behave differently to single 
tissues are isolated in culture.  
Animal studies are more realistic as an entire living organism is being studied rather than 
cells in culture.  Many animal studies have also shown that light exposure has an adverse 
effect on the retina and on MPOD and that increased MPOD can mitigate the effects of light 
exposure, for example Gouras et al. ( 2008); Malinow et al. (1980). Animal studies also have 
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an inherent doubt about the applicability of the results to human populations. The lifespan, 
disease incidence, physiology and response of animals to certain situations are often 
different to our own and therefore the results cannot be guaranteed to apply to humans. In  
common with in vitro studies, the timescales tend to be short compared to the durations of 
exposure thought to create risk in humans and to compensate the light exposure tends to be 
artificially high, creating an environment which does not necessarily ref lect the normal 
development of disease in humans.  
Epidemiological studies have used questionnaires to attempt to assess light exposure over 
long periods of time but these are rather prone to inaccuracy, relying as they do on a 
person’s recall of their history of light exposure and they are prone to other confounding 
factors such as lifestyle choices, use of sunhats and sunglasses which can significantly affect 
exposure levels (Cruickshanks et al., 1992; Ferrini et al., 1998; Threlfall and English, 1999) 
and other factors such as habitual light avoidance in those who may be most at risk of A MD 
(Delcourt et al., 2001),  diet and smoking. There are studies which have attempted to correct 
for these variables as detailed in table 2.1, but there remains a degree of uncertainty. 
Nevertheless, there are studies which have found a correlation between light, MPOD and 
AMD, although others have not (Klein et al., 2004). A recent review and meta-analysis which 
considered 13 epidemiological studies concluded that light exposure is a significant risk 
factor for AMD (Sui et al., 2013) 
Only one study identified has attempted to alter a human individual’s light exposure and 
measure the effects on MPOD. The duration of this study and the light exposu res involved 
was short at only five minutes and as there is known to be a significant time lag to changes 
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in MPOD, from weeks to months (Connolly et al., 2011), it is perhaps not surprising that this 
study did not find an effect (Wenzel et al., 2003). 
Two studies have found an inverse relationship between lens density and MPOD although 
this was also strongly correlated with age. It is therefore unclear whether the relationship is 
causative or not.  It may represent an effect the cataract has on MPOD or an effect that MP 
have on the lens (Berendschot et al., 2002; Hammond et al., 1997), the latter being more in 
line with current theories of the role of MP in the eye.  
Cataract extraction has been used as a proxy for light exposure in two recent MPOD studies, 
one cross sectional study, (Demirel et al., 2013) and one longitudinal study (Obana et al., 
2011), both of which found pseudophakic eyes had reduced MPOD compared to eyes with 
natural lenses. Both studies have potential confounding factors. In the study by Demirel 
(2003) the confounders are potential differences between conditions experienced by the 
two groups, for example differences in diet, light exposure, serum carotenoids and a small 
sample size. In the case of the study by Obana (2011) the confounders are differences in 
behaviour of the subjects after cataract removal with regard to diet or light avoidance and as 
the study was not randomised, there is the possibility of selection bias in the choice of IOL 
used.  
Another longitudinal study by Nolan et al (2009) found that MPOD was augmented in eyes 
implanted with blue blocking IOLs when compared to both clear IOLs and the pre cataract 
removal results. This effect is counterintuitive given that the retinal blue light exposure 
through a blue blocking IOL would still be expected to be greater postoperatively than it was 
through the cataract preoperatively (Romano et al., 2011). The augmentation of MPOD 
observed may be due to systematic measurement differences in MPOD due to the 
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pseudophakia (although this was controlled for with measurements taken shortly before and 
after cataract removal), differences in behaviour between the groups or could be due to the 
mechanism for MP replacement being more complex than assumed.  
These studies give useful information on how long it takes MPOD values to change following 
cataract removal, which occurs over months/years rather than days to weeks.  
Another relevant recent study has found that MP is higher in those wearing UV blocking 
contact lenses, even when factors such as UV exposure are controlled for (Wolffsohn et al., 
2012) despite minimal amounts of UV generally assumed in the adult eye to be reaching the 
retina. This again could point to a feedback mechanism governing MP uptake or deposition 
which is not purely governed by retinal light exposure. 
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Author and year 
Factor 
assessed Type of study  relationship found with r value if stated Variable parameters/exposure  
Number of subjects  
(Raman et al., 2012)  
UV exposure 
and MPOD case control in vivo  Inverse r
2= -0.12 UV based on questionna ire  
33 with AMD, 29 controls 
(Nolan et al., 2009)  Light exposure 
and MPOD 
Case control in vivo  Inverse (augmentation of MPOD in BB group)  Blue blocking up to 500nm Vs UV blocking IOL 21 BB, 21 UV  
(Wenzel et al., 2003)  
Interventional in 
vivo  
None 5 minute exposure 7 μW/cm
2
 400-500nm 
2 
(Obana et al., 2011) Longitudinal in vivo  Inverse R
2
=0.303 exposure:MPOD Blue blocking and clea r IOL implantation 
259, BB121, clea r 138 
(Demirel et al., 2013)  
Cross sectiona l in 
vivo  
Inverse R2 =0.44 exposure:MPOD HFP, cataract removal proxy for exposure  
37 subjects, 68 eyes 
(Mares et al., 2006) Cohort in vivo  None Light exposure based on questionnaire  1698 women 
(Mellerio et al., 2009)  
Cross sectiona l in 
vivo  
Inverse exposure:MPOD Light exposure based on questionnaire  
124 
(Ciulla et al., 2001)  
Cross sectiona l in 
vivo  positive r2=.04 hat and sunglass use:MPOD Sunglass and hat use as proxies for exposure  
280 
(Bone et al., 2001)  AMD and 
MPOD 
Case control Inverse MPOD: Donor eyes with AMD MPOD in eyes with and without AMD 
224 eyes  
(Obana et al., 2008) Case control Inverse F=36.44 Presence of amd:MPOD MPOD in eyes with and without AMD 187 eyes, 97 subjects  
(LaRowe et al., 2008) Cross sectiona l None MPOD in eyes with and without AMD 1698 women 
(Bernste in et al., 2002)  Case control Inverse AMD:MPOD MPOD in eyes with and without AMD 93 AMD eyes, 220 normal 
(Jahn et al., 2005)  Case control none MPOD in eyes at different AMD stages 
146, all with ARM  
(Beatty et al., 2001)  Multiple  AMD 
risk factors 
and MPOD 
Case control Inverse risk:MPOD. r=0.29  for mpod:age MPOD in eyes at high AMD risk 9 eyes at risk, 46 controls  
(Nolan et al., 2007)  Cross sectiona l Inverse Risk:MPOD  r2=0.25 MPOD in eyes of variable  risk  800 subjects  
(Nolan et al., 2010)  Cross sectiona l Inverse r=0.309 MPOD in eyes of variable  risk  853 subjects  
(Berrow et al., 2011) Case control None MPOD and age, smoking and diet (questionnaire)  81 eyes, 16 with A RM 
(Hammond and Caruso–Avery, 2000) Cross sectiona l inverse r=-0.14 for age:MPOD MPOD and age, gender, iris colour, smoking  
217 subjects  
(Raman et al., 2012)  Case control inverse risk:mpod,diet; positive risk:smoking,BMI, UV MPOD and smoking, BMI, diet. 
33 AMD, 29 controls  
(Taylor et al., 1992)  
Light exposure 
and AMD Case control Positive blue light exposure:AMD risk odds  ratio, 1.36 AMD and 20 year exposure based on his tory. 
838 subjects  
(Delcourt et al., 2001)  Cross sectiona l None AMD and light exposure (questionnaire)  2584 subjects  
(Cruickshanks et al., 1993)  Cross sectiona l Positive  
AMD and light exposure, based on le isure time and 
hat/sunglasses use  
4926 subjects  
 (Arnault et al., 2013)  in vitro Positive, greatest damage @420, 430, 440 and 450 nm  
A2E loaded cells exposed s imulated sunlight at multiple  
wavelengths 18hrs.  
  
(Tomany et al., 2004) Cohort longitudina l Positive light exposure:AMD RR for high exposure=2.20 sunlight exposure (questionnaire) and AMD 2764 subjects  
(Fletcher, 2008)  Cross sectiona l none excepting those with low antioxidant intake  Blue light exposure (questionnaire) and AMD 
4753 subjects  
(Cruickshanks et al., 2001) longitudinal positive early exposure:amd risk AMD and early light exposure before age of 30 (questionna ire)  
3684 subjects  
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(Berendschot et al., 2002)  cataract and 
MPOD 
Cross sectiona l  Inverse, β = −.096 Lens density @420NM and MPOD 376 subjects  
(Hammond et al., 1997)  Case control Inverse r = -0.47 Lens density @420nm and MPOD 39 case, 14 control 
(Ciulla and Hammond Jr., 2004) Cross sectiona l none MPOD and cataract requiring extraction 
390, 22 with cataract 
(areds report 22, 2007)  Dietary 
carotenoids 
and AMD 
Case control Inverse OR 0.45-0.73 depending on type of AMD dietary carotenoids and AMD severity  4519 
(Seddon et al., 1994)  Case control Inverse OR =0.57 between highest and lowest intake dietary carotenoids and AMD 356 case, 520 control 
(Moeller et al., 2006)  Cross sectiona l Inverse intermediate AMD and vegetable intake 600, 71 with AMD 
(Snellen et al., 2002)  Case control Inverse OR=1.7 antioxidant and 2.4 lutein intake  neovascular AMD and antioxidant/lute in intake 72 case, 66 control 
(Tan et al., 2008)  Cohort 
Inverse RR 0.35 neovascular AMD for top tertile 
carotenoids  
AMD and dietary antioxidants 
2454 
(Flood et al., 2002)  Cohort None early ARM and dietary antioxidants over 5 years  1989 
(Cho et al., 2008)  Cross sectiona l None carotenoids via food questionnaire and self-reported early AMD 71494 women 41564 men 
( Eye Disease Case-Control Study Group,” 
1993)  
serum 
carotenoids 
and AMD 
Case control Inverse serum carotenoids and AMD 
421 case, 651 control 
(Delcourt et al., 2006)  Case control Inverse OR=0.31 for ARM and plasma lutein  serum carotenoids and AMD/ARM 640 
(Gale et al., 2003)  Cross sectiona l Inverse OR=2.0 for Low Zeaxanthin and AMD serum carotenoids and AMD 380 
(Mares-Perlman et al., 1995) Case control none serum carotenoids and AMD 
167 case, 167 control 
(Malinow et al., 1980) Animal studies 
of MP and 
AMD 
Case control Inverse xanthophyll/fluorescence  Foveal hyperfluorsecence in xanthophyll deprived monkeys 48 
(Leung et al., 2004)  Case control Inverse RPE cell count: dietary carotenoids   RPE ce ll counts  in xanthophyll deprived monkeys 18 case, 15 controls  
(Thomson et al., 2002) Case control Inverse zeaxanthin: photoreceptor apoptosis  3200-lux white light 10x 1 hour 16 quail 
(Sasaki et al., 2012) Case control Inverse lutein:macular thinning  5000 lux for 3 hours  14 case, 5 cont 
(Ham et al., 1978)  
(Gouras et al., 2008)  
case control 
case control 
Positive (RPE lesion produced)  
Positive (drusen spatially associated with lipofuscin)  
1000 seconds  0f 62microW @ 441nm.  
Histological analysis of autofluorescence and drusen  
 
20 eyes rhesus. 
12 eyes Rhesus  
(Sparrow et al., 2004)  
In vitro studies 
of MP/ light 
exposure and 
RPE damage 
In vitro case control Blue blocking IOL reduces cell death 
Blue light Vs clear IOL on A2E loaded RPE  cell apoptosis 390 to 
750 nm; 246 mW/cm
2
 
3x7 different conditions  
(Sparrow et al., 2000)  In vitro case control A2E increases light induced apoptosis  
A2e infused Vs non infused human cells. 480nm and 540nm@ 75 
and 200 mW/mm2 15-60 seconds  
2x3 different conditions  
(Schütt et al., 2000)  In vitro case control A2E increases light induced damage  400–500 nm A2e infused Vs non infused cells 1x2 conditions  
(Zhou and Sparrow, 2011)  In vitro case control Blue light f ilters attenuate apoptosis in A2E infused cells  1 mW/cm2, 30 min 7 conditions  
(Chucair et al., 2007) 
(Siems et al., 1999) 
 
In vitro case control 
In vitro case control 
 
L and Z reduce oxidative RPE  damage 
Photodegradation of  macular carotenoids  
 
Oxidative stress  by h2o2 
Natural sunlight 
 
7 filters  
 
 
Table 2.1: Studies investigating light exposure, macular pigment optical density and age-related macular degeneration.
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2.1.1: Rationale behind study design 
It has been shown that with aging the light transmittance of the lens gradually decreases 
(Sample et al., 1988) and it is thought that this may have an effect on MPOD.  There are 
conflicting experimental results showing what the effect of cataract removal on MPOD is and 
if an effect exists, what the long term trend for MPOD following cataract removal would be.  
Differences between individuals makes unrandomised cohort study results unreliable as a 
number of factors such as UV exposure and diet can effect MPOD, but MPOD is known to be 
similar between the eyes of healthy individuals (Kanis et al., 2007).  
One way to control for confounding factors which affect MPOD and light exposure is to use 
the same patients and compare the effects of light exposure at the same time. A way to do 
this is to study differences between the two eyes of individuals where the two maculae are 
receiving different levels of light exposure, in particular blue light. The need to control for 
other factors such as behaviour, sunglasses use, diet, obesity, and smoking is eliminated as 
they will affect both eyes, so each individual acts as their own control. Monocular effects 
such as ocular disease, direct effects of surgery or differences in physiology between the two 
eyes are left as possible confounders, as is the potential for measurement differences 
resulting from the IOL.  
There are several possible ways to study individuals with different light exposure to the two 
eyes. Modification of the light exposure to one eye though for example tinted contact lenses 
is one method but is difficult to perform in the long term. Alternatively people who have an 
existing difference in light exposure between the eyes, for example those with significant 
anisocoria and those with different light transmission characteristics of the ocular media  
could be studied. The most obvious subjects would be those who have had just one cataract 
83 
 
removed. The advantage of studying subjects who are pseudophakic in one eye is that there 
are several studies which show that removing cataract has no immediate effect on MPOD or 
its measurement with HFP (Ciulla et al., 2001; Makridaki et al., 2009; Nolan et al., 2009)  
although pupil size has also been shown not to affect HFP readings (Wooten et al., 1999). It 
is well known the effect that cataract has on light transmission to the retina and the effect is  
stronger than the effect of pupil size (Charman, 2003). The weaknesses of this study design 
are the possibility that some factor effects both cataract development and MPOD in one eye 
only and the possibility that the cataract itself had a lasting effect on MPOD before it was 
removed. This second effect should be minimised with by the timescales involved in this 
study.  
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2.2: Research concerning macular thickness and MPOD 
There are several mechanisms whereby macular thickness and MPOD may be correlated and 
several studies have investigated this relationship.  
All studies identified have isolated the fovea or central macula as this is where MP is 
concentrated and none have investigated whether there is any thinning of the macula 
outside this area. 
Some have found a positive relationship (Hammond Jr. et al., 1997; Liew et al., 2006; van der 
Veen et al., 2009) and (Zheng et al., 2013) positive only in myopes and others showing none 
or mixed  (Kanis et al., 2007; Kirby et al., 2009; Nolan et al., 2008; Palomo-Alvarez et al., 
2010).  Only one study shows a negative correlation, between retinal thickness and MPOD at 
one and two degrees eccentricity (Westrup et al., 2014) with the same study showing no 
association with central MPOD.  
Nolan et al (2008) found a relationship between foveal width, and not thickness, between 
individuals. These studies are summarised in table 2.2 
A weak correlation between axial length and MPOD has been found in myopes (Tong et al., 
2013) which represents a potential confounding factor although not all studies have found a  
relationship (Neelam et al., 2006). Macular thickness in those without pathological myopia 
have also been shown by some studies not to correlate with axial length (Göbel et al., 2001; 
Ooto et al., 2011; Wakitani et al., 2003) and to show a negative correlation in others (Song et 
al., 2010) and a positive correlation in others (Ueda et al., 2006; Wong et al., 2004). 
Correcting for axial length or other biometry (Neelam et al., 2006) when considering macular 
thickness and MPOD is therefore unnecessary.  
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Author and year Area studied Correlation found Number of subjects OCT  
Liew (2006) 
central 1mm, 
fovea 
r=033 (1mm) and r=0.4 (fovea) MPOD 
0.5° 
612 eyes (all female 
twins under 50) 
SD 
Nolan (2008) 
1mm, fovea, 
fovea width 
r=0.67 at 0.5° in nonwhites for fovea              
r=0.41 foveal width entire study group 
n=18 nonwhites n=59 
entire study group 
SD 
Van der Veen 
(2009)  
fovea r=0.359 fovea at 0.5° n=40 SD 
Zheng (2013) 
central 1mm, 
fovea  
r=-0.66 1mm, r=0.67 fovea in myopes 
only no correlation for entire study group 
n=27 myopic n=94 
entire group 
SD 
Kanis (2007) 
central 1mm, 
fovea 
no correlation 69 eyes SD 
Kirby (2009) fovea no correlation n=16 SD 
Westrup (2014)  
"retinal 
thickness" 
no central correlation, negative 
correlation at 1°  and 2° 
124 eyes n/a 
Palomo-Alvarez 
(2010)  
foveal 
thickness 
no correlation 40 eyes with ARM FD 
 
Table 2.2: studies which have investigated the relationship between macular thickness and 
macular pigment optical density. SD = spectral domain, FD = Fourier domain 
 
There is some evidence from animal studies that there may be a relationship between light 
exposure and macular thickness that MP may modify. Light exposure sufficient to thin the 
retina in mice has been shown in a recent study to be attenuated by dietary intake of L 
(Sasaki et al., 2012) which may indicate that eyes with higher MPOD are less susceptible to 
age related thinning of the macula, hence eyes with higher MPOD as they age would be 
expected to have a thicker macula, however it is important to note that animal studies and 
those using acute light exposure do not necessarily translate to chronic light exposure 
effects in humans. 
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Figure 2.1: The effect of intense 
light exposure on retinal 
thickness in mice with and 
without lutein in the diet. From 
(Sasaki et al., 2012) 
 
 
 
An investigation which measured the effect on macular thickness in individuals who had one 
blue blocking and one clear IOL implanted found no significant difference in macular 
thickness between the two groups after 5 years (Kara-Junior et al., 2011). Unfortunately this 
study did not measure MPOD, so any effect on MPOD is unknown. The study did however 
find there was no difference in low light VA, contrast sensitivity or colour vision between the 
blue blocking and clear IOL. Another recent study found that retinal thinning in the absence 
of visible pathology was associated with loss of contrast sensitivity (Richer et al., 2012) which 
may indicate that retinal thinning is an earlier indicator of age related disease than visible 
ARM.  
In summary, there is conflicting evidence of the relationship between MPOD and foveal 
thickness and no investigations of a relationship between MPOD and the thickness of the 
entire macula. The investigations which have been identified have mostly used lower 
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resolution spectral domain OCT and radial scans rather than cube scans of the macula which 
may lead to lower precision. 
2.2.1: Rationale behind study design: 
There are conflicting results from previous studies which have investigated the relationship 
between macular thickness and MPOD. Studies investigating MPOD have mostly used 
spectral domain OCT and concentrated purely on the fovea and surrounding 1mm diameter 
of the macula where MPOD is highest.  The advent of high definition Fourier domain OCT 
enables higher resolution imaging of the macula and may provide results which have greater 
precision than those used in many studies so far. 
As no previous studies have investigated the relationship between MPOD and the thickness 
of the entire macula area, it is not clear whether the results found which indicate that 
thinner foveae are correlated with lower MPOD are part of a generalised thinning of the 
macula or whether the thinning is specific to the central macula. 
Therefore this study aims to determine if there is a relationship between central macular 
thickness, foveal thickness or average macular thickness and MPOD. This will add to the 
available experimental information as to the  relationship between retinal anatomy and 
MPOD. Although there are other studies into this there are conflicting results. This will in 
turn add to our understanding of the role of MPOD in the development of AMD and the role 
that foveal architecture has in influencing risk of AMD, potentially leading to improved 
identification of those most at risk of AMD and the advice which may be given to those at 
high risk, such as subject which display age related thinning of the macula. 
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2.3: Research relevant to the objective measurement of cataract using OCT 
OCT imaging has not been previously used to provide objective measurements which could 
be used to grade cortical cataract, although it has been successfully used to image the lens 
cortex (DiCarlo et al., 1999) and also to grade nuclear cataract (Wong et al., 2009). 
OCT has been used successfully to measure the thickness of the crystalline lens with better 
reproducibility than A-scan ultrasound although showing a systematically larger 
measurement than ultrasound measurements (Zeng et al., 2009).  
In principle OCT can provide accurate cross sectional images of the lens cortex which can be 
referenced to slit lamp images or histology (DiCarlo et al., 1999). Whether this data can be 
used to provide objective measurements which could be useful to use as clinical information 
when making a decision as to whether to operate on cataract or how much energy might be 
required to emulsify the cataract remains unproven, although other techniques such as 
Scheimpflug imaging have been used for this purpose (Fujikado et al., 2004; Lee and Taylor, 
1989; Ortiz et al., 2008) generally the ability to usefully grade cortical cataract is poor.  
There are several ways to grade cataract objectively, the most common used for research is 
the LOCS III grading system (Chylack et al., 1993) which uses photographic grading scales. 
 Previous to the popular use of OCT, computer analysis of slit lamp images (Maclean and 
Taylor, 1981) and Scheimpflug imaging has been used in a similar way to that proposed here 
to image cataract and provide objective measurements of cataract (Masters, 1996; Sparrow 
et al., 1990). It has not been widely adopted for this purpose however, perhaps due to the 
Scheimpflug instruments not being particularly common. A device described as a dynamic 
light scattering device has been used similarly (Datiles III et al., 2002). Other similar 
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investigations have shown a strong correlation between optical aberrations with cataract 
and contrast sensitivity using wavefront analysis (Kuroda et al., 2002) although the 
association with cortical cataract was not strong. 
Wong et al (2009) used images taken with a Zeiss Visante AS-OCT instrument to grade 
nuclear cataract and found a good correlation with LOCS III measurements of nuclear colour 
and nuclear opalescence. This investigation isolated the lens nucleus using software and 
measured the average pixel brightness across the image, which was itself a composite of two 
images taken (figure 2.1) 
Figure 2.2: The lens nucleus measurements used by Wong et al (2009) to grade nuclear 
cataract using OCT. 
None of these methods have gained purchase in routine optometric or ophthalmological 
practice, with subjective, non-standardised slit lamp assessment and visual acuity 
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measurements still being the most common assessment of cataract used in primary practice. 
No instrument thus far has demonstrated an ability to grade cortical cataract in a useful way. 
2.3.1:  Rationale behind study design: 
This study follows the model of the technique used by Wong et al (2009) whereby the area 
of lens to be graded is scanned using OCT to create cross sectional lens images. The lens area 
of interest is then isolated and analysed using software (figure 2.2). This method has been 
used successfully to grade nuclear cataract using a similar instrument and it was noted in 
that paper that images of the lens cortex could also be acquired in the same way. 
Previous studies have failed to grade cortical cataract in a way which correlates well with 
other measureable aspects of vision. It would be useful to be able to do so in primary 
practice and research. 
Therefore this study aimed to determine the repeatability of cross sectional images through 
the lens cortex and the relationship between vision and lens density. Due to the irregular 
nature of cortical cataract both the lens density and the variability in lens density as 
represented by the standard deviation of the pixel brightness across the image will be 
measured. 
2.4: Conclusion: 
This chapter has set out the research which is relevant to the experimental chapters which 
follow and the rationale behind the research design. The following chapter is the first 
experimental chapter and will investigate the difference in MPOD between the eyes of 
individuals who have one natural aged lens and one clear artificial IOL. 
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Chapter Three 
Experiment one: pseudophakia and macular pigment optical density. 
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In the previous chapter the evidence associating light exposure, MPOD, dietary carotenoid 
intake and AMD has been presented. The rationale for investigating the effect that 
pseudophakia has on MPOD using subjects who are pseudophakic in one eye has been 
explained in terms of good control of confounding factors. This experimental chapter will 
cover the investigation of that relationship and will begin with a summary of the evidence 
base for a relationship between MPOD, light exposure and pseudophakia. 
3.1: Introduction: 
Age-related macular degeneration is one of the leading causes of vision loss in the 
developed world  and is worldwide only second to cataract as a cause of vision loss 
(Congdon, 2003). Many elderly people undergo cataract removal and implantation with clear 
artificial IOLs (McCarty et al., 1999), as do refractive surgery candidates wishing to correct 
ametropa or presbyopia (Horgan et al., 2005). These usually block UV light but greatly 
increase the exposure of the retina to blue light which the aging lens absorbs (Mainster and 
Sparrow, 2003).  
Blue light is thought to be a major hazard to the aging retina due to its high energy and 
photoreactivity with lipofuscin, an age related accumulation of lipid rich cellular waste and 
debris (Sparrow et al., 2000). When blue light reacts with lipofuscin it produces ROS which in 
turn damage the RPE which supports the health of the photoreceptors  (Schütt et al., 2000). 
Blue light has been show to induce apoptosis of RPE in vitro both with and without the 
presence of lipofuscin fluorophore A2E (Rezai et al., 2008). 
Oxidation caused by normal cellular metabolic processes and photooxidation is thought to 
contribute to the aging processes in the RPE which lead to macular degeneration through 
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the depositing of lipid rich material in Bruch’s membrane (Suzuki et al., 2007). This can lead 
to either atrophy of the RPE and photoreceptors known as geographic atrophy or vascular 
proliferation in the choriocapillaris leading to haemorrhage and scarring, known as wet 
macular degeneration (Ambati et al., 2003). Light exposure may be positively correlated with 
AMD risk (Sui et al., 2013). 
It is thought that cataract removal may increase the risk of developing AMD due to a 
combination of postoperative inflammation or an increase in light exposure  (Klein et al., 
2012). There is conflicting evidence from epidemiological studies as to whether the risk of 
AMD in pseudophakics does indeed increase although a recent meta-analysis concluded that 
it is a risk comparable to smoking (Chakravarthy et al., 2010). IOLs which block blue light 
theoretically offer some protection against blue light damage to the retina relative to a clear 
IOL but this remains to be proven (Cuthbertson et al., 2009). 
MP is thought to offer barrier protection and antioxidant protection against the blue light 
hazard and ROS generated by metabolic processes (Kijlstra et al., 2012). It is selectively taken 
up into the central macula region from the serum and deposited in the retina anterior to the 
RPE where it can act as a barrier against blue light (Li et al., 2010). 
MP cannot be measured directly in the living eye. Instead the optical density due to the MP 
is measured, the MPOD. There are several ways of measuring MPOD with both objective and 
subjective tests (Howells et al., 2011). The test chosen for this research is the psychophysical 
method of HFP, which is commonly used in research and has been proven to provide 
consistent results in the presence of cataract and in pseudophakics  (Ciulla et al., 2001; 
Makridaki et al., 2009; Nolan et al., 2009). It is thought that low levels of MPOD may be a risk 
factor for AMD but research results are conflicting (table 2.1). Supplementation with MP has 
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been associated with increased MPOD and a reduced risk of AMD progression in those with 
low dietary intake (The Age-Related Eye Disease Study 2 (AREDS2) Research Group, 2013). 
It is thought that MP is photobleached and destroyed by ROS and requires constant 
replacement (Mortensen and Skibsted, 1997). It is likely that increased light exposure will 
therefore reduce the MPOD unless there is a homeostatic mechanism in the retina to keep 
the MP levels stable. No such mechanism has been identified but has been proposed (Nolan 
et al., 2009). 
This experiment is to determine if pseudophakia with a clear IOL reduces MPOD. The 
proposed mechanism for this change is that the greater light exposure to the retina 
following cataract removal may photobleach and oxidise MP in the retina, leading to lower 
MPOD. If there is no homeostatic mechanism for maintenance of MP levels in the retina it 
would be expected that pseudophakia would reduce MPOD.  
Several studies have measured MPOD in pseudophakics and compared the levels to pre-
operative results or a phakic control group. These studies vary in design with three 
longitudinal case control studies, one of short duration (Ciulla et al., 2001) which found no 
change in MPOD and two of longer duration (Nolan et al., 2009; Obana et al., 2011) both of 
which found a relative difference in MPOD between blue blocking IOLs and clear IOLs, but 
with different absolute results. Nolan et al using HFP found an increase in MPOD in 
individuals implanted with blue blocking IOLs and stable levels in those with clear IOLs. 
Obana et al using Raman spectroscopy found a decrease in MPOD with both blue blocking 
and clear IOLs which was less in the blue blocking group. A cross sectional study by Demirel 
(2013) found lower MPOD in those who where pseudophakic than those who were not 
although the size of the pseudophakic group was small, only 11 subjects. 
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No studies identified have compared the interocular difference in MPOD of those who are 
pseudophakic in one eye and phakic in the other.  This chapter concerns the investigation of 
the effect that cataract removal has on MPOD. Subjects having a clear artificial intraocular 
lens and the other eye a natural aged crystalline lens in the other were studied. It is well 
established that this will result in increased exposure of the retina to light, particularly blue 
light, in the pseudophakic eye. MPOD was measured by flicker photometry. 
3.2: Study aims: 
The principal aim of this study was to determine if there is an in vivo effect of cataract 
removal and by inference light exposure on MPOD. The results of this study have potential 
implications for the risk of AMD after cataract removal and artificial intraocular lens 
implantation. Both the choice of lens implant and the advice given to patients considering 
this procedure may be influenced by the results of this study, particularly those who have 
only mild cataract but also have signs of ARM or those who have IOL implantation 
performed at a young age 
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3.3: Methods: 
The tests used were carried out over two sessions, with the first being the patient’s usual 
routine eye examination. During this examination, the patient’s general suitability for the 
study was assessed. In patients who had one pseudophakic eye the probable suitability for 
the study was assessed before they were invited to take part in the second session using the 
tests carried out as part of a normal sight test.  
 
3.3.1: Subjects: 
The criteria used during this first session for invitation to the second stage were as follows: 
Pseudophakia:  
One eye only, of greater than 3 months duration. It is  possible that shorter timescales would 
not allow any effect to be manifest as MPOD is often found to be relatively stable over the 
course of months or even years (Bernstein et al., 2012). 
Age:  
Over 50, to ensure a significant difference in blue light transmission through the two lenses 
due to there being sufficient lens yellowing for this to be the case in those over this age 
(Kessel et al., 2010). 
Visual acuity:  
Better than 0.4 LogMAR in the phakic eye and better than 0.1 logMAR in the pseudophakic 
eye. Subject with a VA less than 0.4 LogMAR were excluded. This figure is based on a study 
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showing no difference in MPOD measured with HFP shortly before and after cataract 
removal (Ciulla et al., 2001) which used Snellen 6/15 as their cut off point. The effect that 
greater cataract than this was likely to have on the ability to reliably perform the MPOD test 
is unknown. Similarly Nolan et al (2009) used a cut-off point of 0.5 logMAR. 
Different exclusion criteria were used in the two eyes as it was likely in the subjects used 
that in the absence of any disease other than cataract, the VA would be better in the 
pseudophakic eye. 
Amblyopia:  
Patients with amblyopia were not considered due to possible effects on flicker sensitivity 
and fixation instability or inaccuracy which is often shown on visual field testing.  Amblyopia 
was determined using binocular vision tests and the patient’s historical record.  
Ocular Health:  
Patients with AMD were excluded from the study due to uncertainty as to whether this 
would affect the results. It is known that ARM affects the ability of the retina to detect flicker 
and any small scotomas may affect the ability of the patient to see the target accurately 
(Feigl, 2009). 
Patients with visible drusen, pigmentary changes or RPE atrophy at the macula (2 disc 
diameters from the fovea) were not invited to take part in the study. Patients with drusen 
outside this area were not excluded as these are not thought to be associated with AMD 
(Munch et al., 2010; Postel et al., 2005). 
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During the second session using the OCT any subjects with RPE thickening, atrophy or drusen 
within the 6mm2 scan area were excluded from the study, as were any patients with 
epiretinal membranes or other macular pathology within the scan area. 
Patients with corneal opacities or significant vitreous floaters were excluded.  
General health: 
The MPS test is a psychophysical test which relies on good mental abilities to complete 
accurately. Patients with diagnosed or suspected dementia, those with arthritis affecting the 
hands, back or neck in a way which could cause difficulty in comfortably completing the test, 
those unable to complete an accurate visual field examination and vulnerable individuals 
who were unlikely to be able to consent were not considered suitable for inclusion. A good, 
accurate performance using the Zeiss FDT field screener was considered essential for 
inclusion. A patient unable to perform well on the FDT was unlikely to be able to perform the 
MPS test accurately as the FDT requires good reaction times and concentration, as does the 
MPS. 
Anisocoria: 
To be included the pupil in the pseudophakic eye should be no more than 1mm smaller than 
the fellow eye under scotopic conditions simulating daylight using the slit lamp. 
Subjects taking supplements containing L, Z or MZ were also excluded. 
If these criteria were satisfied, the patient was invited to participate in the study during a 
second session, typically of 40 minutes to one hour duration. Informed written consent as 
approved by the Aston University Ethics Committee was gained and the study was 
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performed in accordance with the Declaration of Helsinki. The consent form used is included 
in appendix four. No expenses or reward were offered for participation. 
3.3.2: Materials and procedures 
MPOD measurement: 
After an explanation and consent being obtained, the subject was given a demonstration of 
the MPOD test before the measurements were taken to accustom them to the task.  
MPOD was measured using a commercial MPOD screening device, the MPS, also variously 
known as the MPS 9000, Quantifeye, and most recently the name has been standardised 
across markets to MPS II. It has been confirmed with the distributor (Topcon UK) that all 
these devices are exactly the same except for colour and logos.  
Figure 3.1:  The MPS instrument used for this 
research project in position. The patient response 
button is to the left. 
 
 
The device itself is based on the body of a Henson 7000 visual field screener. It measures 
one eye at a time, with the other occluded using an eye patch and is controlled via software 
on a connected PC and a patient response button. The test has two aspects, first a central 
test to measure MPOD and then a peripheral test, the purpose of which is largely to exclude 
the effects of lens yellowing. For this test the instrument was mounted on the translating 
100 
 
table of a combi unit with adjustable height chair as per figure 3.1. The unit itself also has a 
small range of movement to allow optimal positioning for the comfort of the subject.  
The instrument is linked to a computer via USB and the results can be seen plotted in real 
time as the patient is performing the test, allowing the responses to be monitored. The 30 
degree screen is LED illuminated with a uniform 250Cd/m2 and has 3 LED fixation targets,  a 
central point (1 degree subtense) which provides the flickering stimulus and two red 
peripheral targets of size 1.75 degrees  at 8 degrees from the centre. The left red target is 
used when testing the right eye and the right target when testing the left eye (figure 3.2). 
 
Figure 3.2: The subject’s view of the M|POD test during central testing (L) and peripheral 
testing (R). The difference in colour between the red dots is an artefact. 
The central target is composed of 2 LEDs, one blue (465 nm) and one green (530 nm). These 
two stimuli flicker initially at 60Hz and the instrument gradually ramps down the frequency 
to a minimum of 6Hz. At the point the subject was able to detect the flickering, they pressed 
the button, the instrument beeped to confirm the press and a corresponding point appeared 
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on the screen of the connected computer. The first five cycles serve to determine the flicker 
sensitivity of the subject in order to set the starting point for the test.  
After a short pause the test begins, with each cycle repeated with a differing ratio of 
brightness of the blue and green LEDs. As the ratio changes, the flicker becomes initially 
harder, then after a minimum point, easier to detect at a given frequency. The blue:green 
brightness ratio at which the flicker is hardest to detect represents the point at which the 
brightness of the blue and green are perceptually equivalent, from which the amount of blue 
absorption of the retinal tissues can be deducted. The same test is then repeated with the 
subject looking at one of the peripheral targets  (right target for left eye and vice versa) 
which places the blue light at eight degrees from the fovea where it is assumed there is little 
or no macular pigment. 
This point gives the ratio of blue to green which is equally bright to the subject in the 
presence of minimal macular pigment. The difference between these two values is then used 
to calculate the effect of the blue absorption of the MP on the flicker perception, and hence, 
presuming the only variable between the two tests is the MPOD (figure 3.3). If, for example 
there was a complete absence of macular pigment, the curves should be the same although 
if this were to actually occur the more likely explanation would be a fixation error by the 
subject (figure 3.4). 
The formula for deriving MPOD given by Snodderly et al. (1999) 
MPOD = log 1/TMP = log (B fov / B ref) 
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Where TMP is the transmission of light through the MP, B fov is the blue light intensity 
required to minimise flicker at the fovea and B ref is the blue light intensity required to 
minimise flicker at the peripheral location.  
 
Figure 3.3: a plot of the central (blue) and peripheral (green) curves using the MPS 
 
Figure 3.4: a probable fixation error plot or zero MPOD. 
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The test was conducted in the same room as the measurements taken during the subjects’ 
routine sight test and slit lamp measurements and was quiet for the duration of the test 
aside from occasional advice/encouragement as deemed appropriate by the operator (MS). 
The subjects were required to perform the test twice on each eye to allow assessment of the 
repeatability of individual measurements and allow averaged measurements to be used in 
the final calculations. The sequence of tests was as follows: Right central, right peripheral, 
Left central, Left peripheral, Break (at which point macular thickness measurements were 
taken using OCT), Left central, left peripheral, right central, right peripheral.  
This sequence was chosen to minimise both learning and fatigue effects. Randomisation was 
provided by the fact that the eye which had an artificial IOL was independent of the test 
sequence and it was assumed that whether the right or left eye had developed the cataract 
which had been removed was random. 
The fellow eye was covered with an eye patch to aid concentration and the subjects wore 
their habitual distance correction if required.  
The measurements taken follow a similar protocol to the one suggested by (Howells et al., 
2013b) and the data analysis also follows some of the suggestions from the same study to 
improve test reliability, namely rejection and repeating of curves not considered optimal and 
adjustment of curves with ambiguous minima. Subjects were advised to blink frequently and 
shift their fixation slightly within the red target to avoid the troxler effect where an image 
static on the retina can seem to disappear. 
As the results are displayed in real time whist the operator is watching, there is an 
opportunity to assess the accuracy of the result during the test. If the patient was producing 
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a curve which was not smooth or reliable, the test was stopped and the subject was given 
advice on performing the test accurately. If after 3 attempts a reliable result could not be 
obtained, the test was stopped and the results were not included in the final analys is 
Visual acuity: 
Visual acuity was measured using a directly projecting Nidek CP670 chart projector with the 
patient wearing their best correction immediately following subjective refraction. MPOD 
measurements and VA were taken with the same correction in place. Subjective refraction 
was performed with a Nidek RT-5200 computerised phoropter with normal room 
illumination and VA measurements taken through the same device. 
Pupil Diameter:  
Pupil diameter was measured using a slit lamp under diffuse illumination to simulate 
photopic conditions similar to those experienced in normal daylight and measured using a 
graticule on the slit lamp. 
Age related maculopathy: 
Two methods were used to detect age related macuopathy, fundus photography and OCT 
scans of the macula. Fundus photographs were taken with flash in darkened conditions using 
a Topcon NW6s fundus camera approximately 30-60 seconds apart as required to allow pupil 
redilation. The images were recorded using a Nikon D90 digital camera and Topcon 
imagebase software at a resolution of 3 megapixels and a 45 degree field of view, custom set 
white balance and using JPEG compression. White balance was set by taking a reading 
through the fundus camera with flash using a white card. These pictures were taken during 
the patients routine eye examination, not during the same session as the MPOD 
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measurements and research shows this is a reliable way to assess the fundus for AMD 
(Bartlett and Eperjesi, 2007). During the second session between the first and second set of 
MPOD measurements the central 6mm2 of the macula was also analysed using OCT scans 
taken with a Zeiss Cirrus 4000 Optical Coherence Tomography instrument (Zeiss Meditec, 
Jena, Germany). 512x128 raster scans were taken from each eye. These were the same scans 
used to provide the macular thickness measurements used in chapter four. 
3.3.3: Statistical analysis and Sample size calculations: 
Using mean and standard deviation from Bartlett et al (2010) for MPOD it was determined 
that 18 subjects would be required to detect a difference of 0.1 between the two eyes using 
a paired t test. 30 subjects were recruited to allow for dropouts, those with disease detected 
on the second session and those unable to complete the MPS test.  
Statistical analysis was undertaken using IBM SPSS version 20 for Windows and Microsoft 
Excel 2010 for Windows. Bland-Altman analysis was used to determine repeatability, 
correlations were determined using Pearson’s or Spearman’s correlation coefficients as 
appropriate depending on whether the data was normally distributed and means we re 
compared using paired t tests. Two tailed test were used in all calculations. 
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3.4: Results: 
Thirty subjects were recruited as planned for this study. Some were excluded from the final 
analysis for the following reasons: 
ARM detected on OCT scan which was not visible on fundus photographs: 2 subjects . 
Inability to perform the MPS test accurately after three attempts on both eyes: three 
subjects. 
Data from the remaining 25 subjects was included in the final analysis. Two of those subjects 
only managed to produce one accurate MPOD reading on one of their eyes, but in these 
cases the reading was considered sufficiently reliable to use based on the shape of the 
curves produced. The remaining 23 subjects managed to produce two smooth central and 
peripheral curves on both eyes with well-defined minima within three attempts at each 
curve. 
The majority of the patients recruited were -0.1LogMAR or better in the pseudophakic eye 
as a consequence of the other exclusion criteria effectively eliminating anyone with any 
ocular disease which would reduce VA below these levels 
Repeatability of MPOD measurements: 
To determine the repeatability of the MPOD measurements, Bland-Altman analysis was 
applied to all the individual measurements where two good sets of curves were produced.  
The coefficient of repeatability, representing the 95% confidence intervals of the individual 
measurements was 0.17. The mean of the difference between individual measurements was 
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0.02 +/-0.09.  There was no significant difference between the mean difference of the two 
measurements and zero, one sample t test, t=1.75, p=0.86.  
 
Figure 3.5: A Bland-Altman plot of the difference between the measurements against the 
mean of the two measurements. N=52 
 
Age:  
The median age of the subjects recruited was 73 years old, with a range from 52-89 years 
old. The mean age of the subjects used in the data analysis was 69 years old.  A Shapiro-Wilk 
test on the data showed the age data was not normally distributed (SW statistic = 0.851, 
p=0.002).There was not a statistically significant correlation between age and the mean 
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MPOD of the two eyes. (Spearman’s rank correlation coefficient r=0.059, p=0.779). For 
correlation graph see appendix 1.1. 
Time since operation:  
The median length of time since the cataract operation was 42.5 months, with a range from 
three months to 432 months, (36 years) although 20 of the 25 subjects had been 
pseudophakic less than 100 months. The time between the measurement and the operation 
was not normally distributed (Shapiro Wilk test: 0.69, p<0.001). 
There was no correlation between the difference in MPOD between the pseudophakic eye 
and the fellow eye and the time since the operation (r=-0.16, p=0.940). For correlation graph 
see appendix 1.2. 
If the results up to 100 months were calculated alone to bring the timescales involved in line 
with previous similar studies (Demirel et al., 2013; Nolan et al., 2009; Obana et al., 2011), 
there was a stronger correlation, (r=0.424) but this was still not statistically significant, 
(p=0.056, 2 tailed test, n=20), although this would have been significant if only an increase 
difference in MPOD with time had been hypothesised (one tailed test; p=0.028). For 
correlation graph see appendix 1.3 
MPOD: 
Mean MPOD for all eyes was 0.308 +/-0.16. Mean MPOD for the pseudophakic eyes was 
0.254 +/-0.16 and for the fellow eye was 0.363 +/-0.15. There were 9 pseudophakic right 
eyes and 16left. 
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MPOD values were normally distributed for the MPOD values taken for each eye tested, 
(Shapiro-Wilk statistic 0.971, p=0.255) and also for the mean of the two MPOD values for 
each individual (Shapiro-Wilk statistic 0.965, p=0.517). . 
There was a statistically significant difference between MPOD values in the pseudophakic 
eye compared to the fellow eye with the natural crystalline lens remaining . The mean 
difference between the pseudophakic and phakic eyes was 0.110 with a 95% Confidence 
Interval of 0.05 to 1.70 (Paired t test, t=3.777 p=0.001). 
  
Figure 3.6: A box plot showing the difference in values between the phakic and 
pseudophakic eyes. The central line represents the median, the box represents the 25th to 
75th percentile, the whiskers represent the minimum and maximum values and point 19 
represented by the circle is an outlying value.  N=25 
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3.5: Discussion: 
The coefficient of repeatability found here between the individual measurements is similar 
to other studies using the same instrument (Howells et al., 2013b; Loughman et al., 2012; 
van der Veen et al., 2009). Howells et al. (2013) found that using the average of two 
measurements reduced the coefficient of repeatability (CR) from 0.17 to 0.09 which is 
similar to other methods of MPOD measurement using HFP (Loughman et al., 2012). It was 
the average of two measurements used in the calculations of MPOD. There was no statistical 
difference between the first and second MPOD values. 
The values for MPOD found in this study in phakic eyes are in line with a previous study 
which tested the MPS in a clinical setting (Bartlett et al., 2010b) whereas the values found 
for pseudophakic eyes are significantly lower. This result shows that there is a statistically 
significant relationship that MPOD is on average 0.11 lower in pseudophakic eyes than in the 
fellow phakic eye. The magnitude of the effect demonstrated here is similar to that found by 
the two studies discussed earlier that have found loss of MPOD post operatively (Demirel et 
al., 2013; Obana et al., 2011) of around 0.1.  
The most likely cause of this result is the in vivo degradation or photobleaching of the 
macular pigments or due to the increased oxidative load which results from light exposure or 
inflammatory processes caused by the operation itself.  
Given this result it is unlikely that there is any significant homeostatic mechanism in the 
retina to replace lost MP whereby the retina responds to lower MPOD by increasing uptake 
from the serum. It would appear that MPOD is therefore limited by the rate of renewal of 
the pigment as determined by blood serum concentrations, the efficiency of the transport 
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mechanisms that move MP from the serum to the retina and effectiveness of the binding 
mechanisms at the macula.  
There are several implications of this result. Firstly it strengthens the theory that sunlight 
exposure is a risk factor for AMD. Secondly it has implications for the clinical decisions made 
when IOL are implanted and the advice given postoperatively. It also has implications for the 
behaviour of those at risk of AMD and strengthens the evidence base for the advice 
frequently given by optometrists and ophthalmologists that light exposure avoidance is 
desirable, particularly in old age and especially in those who have had IOLs implanted. It may 
also be advisable in light of this result for pseudophakics to supplement their diets with L, Z  
and MZ to counteract the effect of light exposure on their protective MPOD. 
The lack of association between the time since the operation and the difference in MPOD 
readings would indicate that the MPOD tends to relatively quickly stabilise at a new, lower 
equilibrium between uptake and photobleaching rather than continuing to decline over 
many years. however when very long outliers are removed (over 100 months) to bring the 
timescale of this study in line with previous investigations there is a suggestion of a negative 
correlation between the variables (Demirel et al., 2013; Obana et al., 2011).  This is not 
however statistically significant for the number of subjects left for inclusion. This correlation 
might be significant with a greater number of subjects and would be worth investigating 
further, particularly bearing in mind previous studies which have shown a time:effect 
relationship between MPOD and the time since the operation (Demirel et al., 2013; Nolan et 
al., 2009; Obana et al., 2011). 
The limitations of this study are that it has a relatively small sample size and it is not known 
what the preoperative MPOD levels were, so it is impossible to determine if the values 
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measured have changed since the cataract removal as it is presumed they have. This also 
leaves the possibility of there being a measurement bias in the instrument towards giving 
lower readings in a pseudophakic eye. 
 
3.6: Conclusions: 
This research adds to current knowledge of the behaviour of MPOD in the eye, and the risk 
factors for AMD. It strengthens the case for the advice given to patients regarding sun 
protection with regard to AMD risk and indicates that L, Z and MZ supplementation or blue 
blocking IOLs may be a worthwhile intervention to prevent or delay AMD in pseudophakics. 
Further research into this are may include long term trials of the effect of blue blocking IOLs 
or L, Z and MZ supplements on pseudophakics to assess whether there is any normalisation 
of the MPOD levels or reduction in AMD risk. It may also be useful to conduc t a similar 
investigation to this one but with an attempt to measure MPOD both objectively and 
subjectively and to measure light transmission through the non pseudophakic eye to 
attempt to quantify the strength of the effect observed here. A study investigating the effect 
of anisocoria on MPOD may also have the potential to investigate the effects shown here, 
although the number of subjects would need to be large to take account of the smaller 
difference in exposure and the lack of blue light specificity as anisocoria reduces all 
wavelengths equally as opposed to cataract which selectively reduces blue light.  
The next chapter concerns the experimental determination of the relationship between 
three macular thickness parameters and MPOD using Fourier domain OCT to measure 
thickness and the MPS to measure MPOD.  
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Chapter Four 
Experiment two: To determine if there is a relationship between MPOD and macular 
thickness. 
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In the previous chapter it has been determined that MPOD measures lower in pseudophakic 
eyes using HFP than in phakic eyes in the over 50s. This chapter concerns the experimental 
determination of the nature of the relationship between macular thickness and MPOD. 
Macular thickness will be determined by Fourier domain OCT and MPOD will be measured 
by HFP. 
4.1: Introduction:  
Macular pigment optical density (MPOD) represents the in vivo absorption of light by 
macular pigments, namely L, Z and MZ. These pigments are thought to perform an important 
role in the eye as antioxidants and blue light filters (Whitehead A, 2006). MPOD can be 
measured in several ways, using objective and subjective techniques (Howells et al., 2011). 
Of principal interest in this study is the thickness of the fovea where MPOD is highest. The 
thickness of this area is variable between individuals through a number of normal 
anatomical variations and possibly also disease or aging processes (Liu et al., 2011).  
Macular pigment is taken from the blood serum via selective active transport (Li et al., 2010) 
and  concentrated in the outer plexiform and Henle fibre layers (Trieschmann et al., 2007)  
where it acts to block blue light (Kernt et al., 2012) and neutralise ROS generated by photo 
oxidation and metabolic processes (Khachik et al., 1997).  
Macular thinning may be associated with early age related disease of the macula (Richer et 
al., 2012). MPOD has also been shown in some studies to be reduced in those with AMD  
(Bernstein et al., 2012; Bone et al., 2001; Obana et al., 2008) 
There are a number of mechanisms whereby MT and MPOD may be correlated. Both MPOD 
and macular thickness varies between individuals. The two may be correlated through 
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normal anatomical variations altering the capacity of the eye to bind macular pigment, for 
example through a thinner outer plexiform or Henle fibre layer altering the ability of the 
retina to bind MPOD. Alternatively early disease processes may reduce both macular 
thickness and MPOD concurrently as has been shown in AMD. There is also the possibility 
that a lack of MPOD increases the risk of disease processes which cause thinning of the 
retina. 
The outer plexiform layer is known to undergo aging changes and thinning (Gartner and 
Henkind, 1981) and this may alter its capacity to carry MP with thinning leading to lower 
MPOD values. There is mixed evidence as to whether MPOD declines with age, with studies 
using Ramen spectroscopy more likely to show a difference (Howells et al., 2011) and it has 
been suggested that the decline is only found in people with AMD (Kaya et al., 2010) 
Current studies examining the relationship between MPOD and macular thickness have 
produced conflicting results. Most have used time domain OCT which has lower resolution 
than the spectral domain OCT used here and may therefore have a reduced ability to 
determine subtle differences in macular thickness. Previous studies have also only measured 
the central fovea or 1mm diameter of the macula where MPOD is highes t and have not 
determined if there is a relationship between MPOD and the thickness of the wider macula 
area. These studies are detailed in table 2.2. 
Demonstrating the relationship between the thickness of the central retina and MPOD 
would help to increase our understanding of the effect that aging has on the retina and the 
influence of retinal anatomy on MPOD.  
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4.2: Methods: 
4.2.1: Subjects: 
Subjects were chosen from the two other experiments of this research project, into the 
effect of pseudophakia on MPOD and the measurement of cortical cataract.  
This included 40 eyes from 20 subjects with some degree of cortical cataract from 
experiment three and 30 eyes with only moderate cataract from experiment one, so 70 eyes 
from 50 subjects in total were available for this study. Only one eye from each individual will 
be used as macular thickness will not be independent between the two eyes of an individual.  
Not all of the subjects recruited for the cortical cataract study were able to perform a 
reliable MPOD test as the criteria for selection on this study is directed towards patients 
with cataract, so the total number of eyes available was be slightly lower than this number. 
Due to the need to gain a wide variation in cataract, some of the subject had cataracts too 
dense to perform the MPOD test reliably. 
The methods for MPOD collection are as the other two studies, and differ slightly between 
the two groups. For the cortical cataract study the MPOD measurements are only taken as 
many times as is necessary to gain one set of reliable curves with the initial eye randomised. 
For the pseudophakia study the MPOD measurements are taken twice, with the right eye 
always taken first.  
For the group with monocular pseudophakia, the methods for selecting patients and 
collecting data are as described in the preceding chapter. In addition to those criteria 
subjects with evidence of epiretinal membranes or damage to the foveal surface from a 
previous vitreous detachment, or any evidence of vitreoretinal traction were excluded, a long 
117 
 
with epiretinal membranes or previous vitromacular surgery. Even if these were subtle 
enough to be deemed unlikely to affect the MPOD test, they may affect the results of the 
macular thickness measurements.  
Figure 4.1: Examples of minor retinal defects which would invalidate macular thickness 
measurements: A: Mild lamellar damage from previous vitreomacular traction
 
B: vitromacular traction
 
C: epiretinal membrane 
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4.2.2: Materials and procedures: 
For the group recruited for cortical cataract assessment, MPOD data was collected from 
those subjects able to perform the test as determined by the same criteria in the experiment 
one, with the same exclusion criteria. Patients meeting the criteria for the cortical cataract 
assessment who did not meet the criteria for MPOD measurement did not perform the 
MPOD test.  Those who were suitable performed the test 5 minutes after instillation of 0.5% 
tropicamide drops as required for the LOCS III grading for experiment three and before slit 
lamp and OCT tests were performed. The eye tested first was randomised using a random 
number generator. Due to the fact that the tropicamide drops were acting whilst the subject 
is performing the test there will be differences in pupil size as the tropicamide acts but this 
has been shown not to affect the results of the HFP test used (Wooten et al., 1999). 
The MPS test was only performed once on these subjects due to time constraints and due to 
the risk of fatigue and photobleaching from the other tests affecting the results after the 
data collection for the cortical cataract measurements  
The OCT measurements were taken using a Zeiss Cirrus OCT and analysed with version 6.1 
software (Zeiss Meditec, Jena, Germany). Three measurements were recorded – the central 
foveal thickness as measured by the measurement tool integrated within the 6.1 software,  
the average central thickness over both the central area 1mm in diameter and the average 
thickness over the whole 6mm2 scan area as measured automatically by the instrument. 
These measurements have been shown previously in many studies using this instrument to 
have excellent repeatability and reproducibility and were therefore only taken once (Garcia-
Martin et al., 2011; Giani et al., 2010; Ho et al., 2009; Huang et al., 2011) although it should 
be noted that these studies also tend to find poor agreement between instruments from 
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different manufacturers due to the different algorithms used to delineate and measure the 
retinal layers.  
 
Figure 4.2: demonstration of measurements of  foveal and macular thickness. The red line is 
the foveal measurement and the macular thickness measurements are taken between the 
white lines delineating the RPE and ILM. 
As displayed in figure 4.2, the foveal thickness measurement was taken perpendicular to the 
RPE from the centre of the RPE as automatically detected by the Cirrus instrument to the 
bottom of the centre of the foveal pit. The instrument sometimes seems to underestimate 
the depth of the foveal pit as shown in figure 4.3 
 
Figure 4.3: automatic segmentation line underestimating foveal pit depth where the retinal 
surface does not quite correspond with the segmentation line. 
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In these cases the measurement was taken not to the segmentation line provided by the 
instrument but to the foveal pit surface as demonstrated by the red line in figure 4.3. In 
cases where the automatic segmentation failed due to poor signal strength or vitreous 
floaters only reliable measurements were recorded.  
Age was recorded from the patient record and visual acuity data was taken during the 
patient’s routine sight test as described in chapter three. 
Before any measurements were taken the patient’s informed consent to the procedures and 
use of their data was recorded using the consent form. The tests used which were not 
standard routine clinical tests were approved by Aston University ethics committee and all 
tenets of the Declaration of Helsinki were adhered to.  
4.2.3: Statistical Analysis 
The data were recorded on record cards, transferred to Microsoft Excel analysed using IBM 
SPSS version 20 for Windows. Pearson’s correlation coefficient was used for parametric data 
and Spearman’s rank correlation coefficient was used for non-parametric data. All 
correlations use 2 tailed data. Significance was taken as p≤0.05. 
Sample size calculations were undertaken to assess the ability of this study to detect 
differences. Using values of macular thickness from Song et al. (2010.) which gives values of 
275.66 ± 14.12 for overall average thickness and 253.92 ± 24.18 for central subfield thickness 
using the Cirrus instrument a sample size of 43 would be able to detect a 6µm difference in 
average thickness and a difference of 10µm in central retinal thickness for a power of 0.8.  
The number of subjects in this study will be sufficient to detect an r value of 0.30 at the 0.05 
confidence level, or an effect which accounts for 9% of the difference between the variables.  
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4.3: Results: 
Data from 50 subjects were available to the study in total, with 99 eyes being included for 
some measurements, one being excluded from all measurements due to corneal scarring. 
Age and visual acuity were taken for 99 eyes. 20 eyes were excluded from any macular 
thickness measurements due to macular abnormalities which would invalidate the thickness 
measurements. Data was then selected with one eye from each patient analysed. Where 
patients with pseudophakia were used, the phakic eye was used only, on the other subjects, 
the eye used was chosen at random where good data was taken from both eyes and where 
good data from only one eye was available, that eye was selected. This resulted in data from 
43 eyes being used, with all macular thickness measurements, age and VA data available 
from all of these subjects and MPOD data from 41 eyes. 
 
Macular thickness measurements  
Three macular thickness measurements were taken, central foveal thickness, the central 
1mm diameter macular thickness measured by the Cirrus software and the average macular 
thickness over the 6mm2 scan area. The foveal thickness (FT) was not normally distributed 
(Shapiro Wilk statistic 0.945, p=0.048), the central macular thickness was normally 
distributed (Shapiro Wilk statistic 0.962, p=0.184) and average thickness (AVT) 
measurements were normally distributed, (Shapiro Wilk statistic 0.974, p=0.477). The 
median FT measurement was 210µm with a range from 169 to 276, MT measurements were 
265µm +/-21 and AVT measurements were 277µm +/-13 
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All the macular thickness measurements were inversely correlated with age but only the 
central 1mm diameter measurement was statistically significant and the measurements 
were not significantly correlated with VA although the central macular thickness 
measurement was close to being significant (p=0.085). There was a positive correlation 
between all the macular thickness measurements and MPOD but only the average thickness 
over the entire scan area was statistically significant (p=0.039). 
    MPOD Age VA 
Foveal 
thickness 
(FT) 
Correlation 
Coefficient 
.148 -.295 -.138 
Sig. (2-
tailed) 
.356 .055 .376 
N 41 43 43 
Central 
macular 
thickness 
(MT) 
Correlation 
Coefficient 
.185 -.471 -.266 
Sig. (2-
tailed) 
.246 .001 .085 
N 41 43 43 
Average 
macular 
thickness 
(AVT) 
Correlation 
Coefficient 
.324 -.208 -.143 
Sig. (2-
tailed) 
.039 .180 .359 
N 41 43 43 
 
Table 4.1. Correlations involving macular thickness measurements. MT = central 1mm 
diameter thickness; FT = foveal thickness; AVT = 6mm diameter thickness. See appendix 2.1 
for graph of macular thickness plotted against age. 
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MPOD 
MPOD measurements were normally distributed (Shapiro-Wilk statistic 0.975, p=0.482) with 
a mean value of 0.36 +/- 0.15  
There was a statistically significant correlation between the average thickness of the macula 
region and MPOD, but not between the foveal or central macular thickness measurements. 
 
    MT FT AVT Age VA 
MPOD Correlation 
Coefficient 
.185 .148 .324 .064 -.207 
Sig. (2-
tailed) 
.246 .356 .039 .691 .194 
N 41 41 41 41 41 
 
Table 4.2: Correlations with MPOD. MT = central 1mm diameter thickness; FT = foveal 
thickness; AVT = 6mm diameter thickness. See appendix 2.2 for graph of MPOD plotted 
against average thickness.  
Age 
Age was normally distributed (Shapiro-wilk statistic 0.976, p=0.524). Mean age was 72.7 +/-
8.7 years and had a range from 52 to 89 years old.  
Age was significantly correlated with visual acuity and the central macular thickness 
measurements, but not MPOD. 
    MPOD FT MT AVT VA 
Age Correlation 
Coefficient 
 
.064 -.295 -.471 -.208 .472 
Sig. (2-
tailed) 
.691 .055 .001 .180 .001 
N 41 43 43 43 43 
Table 4.3: correlations with age 
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Visual acuity 
VA was not normally distributed (Shapiro-wilk statistic 0.596, p<0.001). Median VA 
(LogMAR) was 0.00 with a range from -0.1 to 0.32.  
VA was significantly correlated with age (r=0.472 p=0.001) 
 
    MPOD FT MT AVT Age 
VA Correlation 
Coefficient 
Spearman’s 
-.207 -.138 -.266 -.143 .472 
Sig. (2-
tailed) 
.194 .376 .085 .359 .001 
N 41 43 43 43 43 
 
Table 4.4: correlations with VA 
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4.4: Discussion: 
This data indicates that there is an association between macular thickness parameters and 
MPOD. The association was found between MPOD and the thickness of the entire macula 
region and not between MPOD and the areas where the MP is concentrated, weakening the 
hypothesis that there is a causal link between the two variables. It may indicate rather that 
there is a general decline of MPOD with the health of the macular region in general, rather 
than the availability of the binding sites being a limiting factor on MPOD. 
It may be that maculae that are less healthy have less pigment and a general thinning of the 
retina, possibly caused by early dysfunction of the RPE affecting MP uptake rates. If the 
thinning was being caused by a lack of MP directly it would be likely that a preferential 
thinning of the central 1mm2 of the macula would be seen as this is the area protected by 
the MPOD. Another possibility is that this finding represents early RPE dysfunction which has 
not yet affected the central 1mm2 of the retina due to the protective effect of the  MPOD. 
This may be related to the phenomenon of foveal sparing seen in many patients with 
geographic atrophy of the macula which tends to start in the perifovea where MP is lowest. 
These results must also be interpreted with caution as multiple comparisons were made and 
the correlation between the AVT measurements and MPOD was not very strongly s ignificant. 
Had a criteria of p≤0.01 been used instead to take account of the multiple comparisons this 
would not have been considered a significant result. Further study with a larger number of 
subjects is needed to confirm this finding. 
The methods for the MPOD test varies between the subjects recruited for the two main 
wings of the study in that in the subjects recruited with cortical cataract, the test was only 
performed once. It would have been more desirable to perform this test twice as with the 
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other study but this would probably only have been feasible with a third visit by the subjects, 
with the inconvenience involved which it was decided outweighed the benefits, particularly 
with a study which involved a number of elderly subjects.  The difference in methods did not 
appear to affect the results of the MPOD test as both the mean and standard deviation were 
similar, and close to the values reported by similar studies (Bartlett et al., 2010b). The Bland-
Altman analysis of the data in chapter 3 shows the individual MPOD readings had a CR of 
0.17 and no systematic difference between the first and second readings. 
Although the statistical power of this study is not as great as some previous investigations, 
this is the only study identified which compared the thickness of the entire macula region 
with MPOD, rather than just the small central area in which MPOD accumulates, and which 
some previous studies have found has a relationship with MPOD. The majority of the 
previous studies have used time rather than spectral domain OCT which has a lower 
resolution. Longitudinal studies measuring thickness and MPOD may be able to determine 
the relationship between these variables. No significant correlation between MPOD and any 
of the other variables was found, indicating that MPOD is not significantly affected with age 
within the limited range tested and is not significantly affected by foveal or central macular 
thickness within the power of this study. 
 Significant correlations were found between macular thickness and age, which is in line with 
a previous study using the same instrument and with a similar rate of change detected (Song 
et al., 2010.). Visual acuity was also shown to decline with age as might be expected, 
particularly in the group of patients selected many of whom had cataract, an age related 
disease (Klein et al., 1991).  
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These results indicate that there is no significant effect of foveal architecture on the 
accumulation of macular pigment. This indicates that the limiting factors on MPOD do not 
include the foveal architecture and by implication the ability of the macula to bind MPOD, 
indicating that factors such as dietary intake, uptake rates from the serum and clearance 
rates through oxidation and bleaching caused by light exposure are more important.  
This study specifically excluded any subjects with traces of macular disease, and this may be 
why there is no association between the two variables found. It may be that studies showing 
an association between MPOD and central macular thickness  (Hammond Jr. et al., 1997; 
Liew et al., 2006; van der Veen et al., 2009)  are detecting differences which are due to the 
early stages of AMD, which is known to reduce MT and MPOD and this may also explain the 
relationship found between AVT and MPOD here which may both be a result of early RPE 
dysfunction due to oxidative stress, light exposure or hypoxic stress. The lack of a 
relationship between central macular thickness and MPOD may be due to the relative 
sparing of the central macula from stress by the presence of macular pigment. The results 
also indicate that the decline in MPOD seen in pseudophakic patients is not due to a change 
in macular thickness. 
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4.5: Conclusion: 
This data does not support the hypothesis that MPOD is determined by central macular 
thickness, but does confirm that macular thickness declines with age and does find that 
there is a relationship between average macular thickness and MPOD which may not be 
causal.  
This result agrees with some published studies  (Kanis et al., 2007; Kirby et al., 2009; Nolan 
et al., 2008)  which have found no association between MPOD and central and foveal 
macular thickness but contradicts others  (Hammond Jr. et al., 1997; Liew et al., 2006; van 
der Veen et al., 2009). This appears to be the first study associating average macular 
thickness with MPOD. Further study into this area might investigate whether the effects of L, 
Z and MZ supplementation on MPOD are affected by macular thickness and whether any 
correlation independent of factors such as cataract between visual acuity and macular 
thickness is present. It might also be interesting to conduct a larger s tudy into whether the 
effect found here is repeatable and whether any significant correlation between central 
macular thickness and MPOD in a study of subject without macular disease can be shown or 
whether the effects demonstrated in earlier studies are attributable to the presence of 
subjects with AMD.  
Since OCT instruments have become more widespread, collecting data on macular thickness 
is a routine practice in some optometry practices now and this bank of data might be used in 
further studies. Turning this newly widespread technology on other areas of the eye such as 
the crystalline lens is an obvious area of potential study, which is where the next chapter 
progresses to. 
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Chapter Five: Objective measurements of cortical cataract using Optical Coherence 
Tomography 
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In the previous chapter OCT was used to measure various parameters of macular thickness 
in order to determine their relationship with MPOD and a statistically significant correlation 
was found between MPOD and the thickness of the 6mm diameter region of the macula. 
This Chapter concerns an attempt to perform objective quantitative grading of cortical 
cataract using a commercial Optical Coherence Tomography (OCT) instrument with a 
wavelength of 840nm. Cortical cataract assessed using the popular LOCS III grading scales 
was compared to lens density readings obtained using a Zeiss Cirrus OCT instrument 
scanning through the lens in cross section. 
5.1: Introduction 
OCT is a relatively new (Huang et al., 1991) but rapidly maturing technology with various 
applications in manufacturing (Dunkers et al., 1999), dentistry (Otis et al., 2000), vascular 
imaging (Brezinski et al., 1996) and in its most mature application, ophthalmology. It is 
analogous to ultrasound using light rather than sound waves and creates non-invasive cross 
sectional images through semi-transparent tissues, with the depth, field of view and 
resolution being determined by the tissue to be examined, the optics of the instrument and 
the wavelength and bandwidth of the light used (Wang et al., 2003). 
 Its resolution is superior to that of magnetic resonance imaging (MRI), computed 
tomography (CT) or ultrasound, and less invasive with no danger from metallic objects, 
ionising radiation or contact via coupling solutions, although these other techniques all have 
their advantages such as the ability to image posterior to the sclera and their differing 
abilities to measure certain types of tissue (Huang et al., 1991). 
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The eye is an ideal subject for the technology with various parts being transparent by 
necessity in order to let light penetrate to the photoreceptors at the posterior pole. The 
cornea, lens and retina are all multi-layered semi-transparent tissues which can be reliably 
imaged with OCT. Anterior segment OCT was first described by Izatt et al., (1994) and 
generally uses an illumination source of a superluminescent diode of wavelength 1310nm as 
opposed to posterior segment instruments, which generally now also have anterior segment  
capabilities, which use wavelengths around 840nm. The anterior segment OCT uses the 
longer wavelength due to the greater penetration of the sclera at this wavelength, allowing 
limited imaging of the ciliary body and the greater field of view it provides. Posterior/ multi -
application OCT uses the shorter wavelength to improve the resolution for accurate imaging 
of the layers of the retina and to reduce light scattering in the anterior and posterior 
chambers. 
 
Figure 5.1: OCT image of the retina at 840nm  
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Figure 5.2: OCT of the anterior chamber at 1310nm. From www.meditec.zeiss.com  
 
Figure 5.3: OCT of a narrow anterior chamber angle at 840nm. Note the small field of view, 
higher resolution and shallower tissue penetration compared to figure 5.2. 
Cortical cataract is cataract which affects the outer layers of the lens, the cortex. It is known 
to be associated with UV light exposure (Cruickshanks et al., 1992; Taylor et al., 1988).  It 
often appears as radially arranged spokes of opacity with relatively clear lens in between 
(figure 5.4) 
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Figure.5.4: Cortical cataract viewed with retroilllumination. 
 This makes it challenging to grade in a way that reflects the visual effects which often vary 
depending on the location and type of opacity. Grading scales of cataract do no t always 
relate well to visual acuity (Wong et al., 2009), but it is visual acuity which is used as one of 
the criteria to assess NHS patients for eligibility for cataract removal and is also used as one 
of the legal minimum standards for vision required for driving. This leads to the question of 
whether grading scales for cataract or visual acuity is the better assessment of whether an 
individual should have their cataract removed. Although symptoms are also heavily 
weighted in clinical decisions, these also often correlate poorly with objective measurements 
of vision and cataract. 
The instrument used was an 840nm, posterior segment based instrument with anterior 
segment capabilities via a 60D additional lens, the Zeiss Cirrus (Zeiss meditec) The reason 
this instrument was chosen is that these instruments are increasingly widespread in primary 
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practice and ophthalmology units, making it likely that routine cataract grading in primary or 
secondary practice using OCT would use instruments of this type. The depth of the cortex 
increases with age and the scan depth of the 5 line anterior raster scan, which using the 
instruments internal measuring tool is 2mm is sufficient to image the entirety of the lens 
cortex reliably (Dubbelman et al., 2003). 
Figure 5.5: Imaging of the anterior segment using an experimental OCT with a wavelength of 
1050µm showing the lens as a whole: From (Li et al., 2013). 
It was proposed that images of the central cortex and an analysis of the density of those 
images might provide information which is more pertinent to the visual status of the subject 
than the LOCS III grading scales. LOCS III enables subjective grading of cortical cataract on 
the presence of lens opacities visible when the pupil is dilated to over 6mm which in many 
cases might lie outside the area of the lens through which the subject is seeing, being hidden 
behind the iris when the pupil is undilated.  Grading cataract with a slit lamp through an 
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undilated pupil however is often impossible due to senile miosis and the light mediated 
constriction of the pupil when the bright slit lamp beam is passed through the lens. OCT 
overcomes these difficulties as the pupil can be physiologically dilated by scanning in 
darkness and the scanning light itself is in the infrared spectrum and therefore does not 
cause significant pupil constriction. Although senile miosis which constricts the pupil below 
3mm would affect the area of lens available to scan through, it is also true that the lens area 
available to scan would be the same as the lens area the patient is looking through. Proving 
in principle that cortical cataract can be graded by simple imaging through undilated pupils 
may lead to more accurate assessments of cataract in primary practice and more accurate 
referrals of those most in need. 
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5.2: Methods: 
5.2.1: Subjects: 
Patients were selected during their routine eye examination due to the presence of cortical 
lens opacities and sufficient overall lens opacities to require pupil dilation to obtain a good 
fundus view and assessment of cataract. Patients were invited to take part in the study and  
if appropriate also perform a macular pigment optical density (MPOD) screening test, as 
described in chapter three.  Not all of the subjects met the criteria for the MPOD screening 
test due to poor VA or macular disease, but these subjects were still assessed for cataract 
due to the need to obtain a wide range of cataract states, some of which would preclude VA 
sufficient to perform the MPOD testing and the fact that the presence of macular disease 
would not affect the cataract grading, indeed the reason some of the denser cataracts had 
not been removed was due to the presence of macular disease in that eye. 
Inclusion criteria was the presence of cortical cataract visible on slit lamp examination in one 
or both eyes in an undilated state during the patient’s routine eye examination which 
clinically warranted pupil dilation to adequately assess the fundus and the cataract itself.  
Exclusion criteria for cataract measurement:  
 The presence of corneal disease (for example Fuch’s endothelial dystrophy) which 
may affect OCT scan intensity, or any corneal opacity within the central 4mm 
diameter of the cornea. 
 Ataxia or an inability to undergo a slit lamp or OCT examination due to, for example, 
neck or back arthritis. 
 Vulnerable people, those with dementia or mental health problems were excluded.  
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 Medications which can affect the opacity of the cornea  
 A history of iritis or uveitis, angle closure glaucoma or narrow anterior chamber 
angles. 
 synechae 
 IOP over 21mmHg  
 Van Hericks grade 1 (narrow) or 0.  
 Pupils noted in records to be resistant to dilation 
Exclusion criteria for MPOD measurement were the same as described in chapter three. 
Measurements used in this research were taken during the patient’s follow up dilation 
appointment.   
Before any measurements were taken the patient’s  informed consent to the procedures and 
use of their data was recorded using the consent form. The tests used which were not 
standard routine clinical tests were approved by Aston University Ethics Committee and all 
tenets of the Declaration of Helsinki were adhered to.  
5.2.2: Materials and procedures: 
Before dilation, IOP measurements and a Van Herick’s angle assessment was undertaken to 
exclude those with a risk of angle closure or abnormal IOP. The patients were dilated using 1 
drop of 0.5% tropicamide in each eye and the MPOD measurements for chapter three taken 
whilst the pupils dilated. MPOD measurements were only taken once and only taken on 
suitable candidates, as outlined in chapter three. Patients unsuitable for MPOD testing were 
asked to wait for approximately 20 minutes after instillation of the drops until the pupils 
were dilated over 6mm. 
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The OCT measurements were taken using a Zeiss Cirrus OCT and analysed with version 6.1 
software (Zeiss meditec). Measurements from only the front surface of the lens were used 
as images from the back surface tend to be rather faint due to absorption of the scan from 
the anterior cortex, nucleus and anterior lens surface, and also because visually significant 
cortical opacities tend to occur in the anterior cortex of the lens, probably due to the greater 
effect of UV exposure. It is also difficult to accurately define the anterior surface of the 
posterior lens cortex on many of the images, as with figure 5.5. 
The settings for the OCT were left as per the factory defaults for brightness, contrast and the 
‘enhance’ function which adjusts the polarisation of the scanning beam. Fourier-domain OCT 
has a peculiarity whereby the image intensity is dependent on where in the frame the scan is 
positioned (Spaide et al., 2008). To ensure this effect does not affect the apparent lens 
density, the scans were positioned with the anterior surface of the lens as high as possible in 
the scan window to achieve consistency between the scans  (figure 5.6).  This was in any case 
necessary to ensure that the entire cortex was imaged within the 2mm window of the OCT 
scan available. The size of this effect was also estimated using two patients from the study 
and analysing corneal images at various scan heights. It is also apparent that the centre of 
the lens curvature does not always coincide with the centre of the pupil as might be 
expected. In these cases the lens was scanned through the centre of the pupil, this being the 
centre of the area through which the subject is looking, rather than the centre of curvature 
of the lens, with the lens again being positioned as far forward as possible. 
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Figure 5.6: OCT section of lens cortex showing lens positioning in the scan window.  
Ten 3mm wide by 2mm depth high definition raster scans were taken from each lens, five 
horizontal and five vertical with the centre measurement positioned on the centre of the 
pupil (figure 5.7). This generates images which can be exported for analysis as either .BMP or 
.jpg files of size 4096x1024. The phenomenon of lens dewarping artefacts noted by Wong et 
al. (2009) is not an issue with these scans as the cirrus software, unlike the visante, does not 
attempt to correct for the warping of the image caused by the refraction at the air-cornea 
and cornea-aqueous interfaces (Leung and Weinreb, 2011) 
  
Figure 5.7 Placement of vertical scans (green lines) 
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Once pupils were dilated past 6mm, cataract was graded conventionally using the LOCS III 
photographic grading scales. Images were graded whilst the patient was at the slit lamp 
using the images provided in the LOCS III paper and photographs taken for records. Images 
were taken using a Topcon SL-D7 slit lamp equipped with a DV-1 camera which records 
images through the right hand eyepiece via a beam splitter. Camera settings were chosen for 
accurate colour rendition in the photographs and jpeg images of size 1280x960 recorded 
using Topcon imagenet ibase software version 3.7.4. The slit lamp was positioned on a 
translating table on a combi unit and connected to a PC VIA USB giving instant display of the 
images taken to ensure the images accurately reflected the view through the slit lamp. The 
measurements were taken in darkened room lighting.  
Three good images that accurately represented the view through the slit lamp were taken on 
each eye, to record nuclear opacity (NO), nuclear colour (NC) and cortical cataract (C). For 
the NC and NO images the slit width was set to 0.2mm, the height to full and the angle to 45 
degrees, as per the methods set out in the LOCS III paper (Chylack et al., 1993). The 
brightness was adjusted by trial and error to give accurate colour rendition and not 
subsequently adjusted. The slit beam was focussed on the centre of the lens to record NO  
(figure 5.8) and the rear of the lens to record NC (figure 5.9). For the C images the lens was 
retroilluminated using a spot and the cortical opacities analysed using the method described  
by Chylack et al. (1993). The LOCSIII grade between 0.1 and 5.9 was recorded. Posterior 
capsular cataract was not graded. 
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Figure 5.8: image showing slit beam positioned for nuclear opalescence measuremen t: the 
back scatter of the slit beam from the lens nucleus is used for grading 
 
Figure 5.9: nuclear colour measurement: the colour of the posterior lens is used for grading. 
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Figure 5.10: retroillumination showing cortical opacities: the area covered by the opacity is 
used for grading. 
Analysis of the OCT images was blinded, with patient identifying details removed. The 
images were imported to ImageJ software where the lens cortex was isolated from the 
image, excluding the strong reflection from the anterior lens capsule (figure 5.11) 
 
Figure 5.11: OCT scan of lens cortex isolated using the polygon selection tool in ImageJ 
software. 
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ImageJ retains the selection from one image to the next, and this was adjusted as required 
between images and invariably required completely redrawing when switching between 
eyes or between the horizontal and vertical sections. The analysis of the corneal images was 
performed the same way. 
To investigate whether image format had any bearing on the results of the analysis, one s et 
of 10 images (5 horizontal, 5 vertical) from one eye was analysed in the two formats the 
Cirrus OCT permits single images to be saved as, JPEG and Bitmap. The file size of the bitmap 
images is approximately 10 times that of the JPEG images due to the greater compression of 
the JPEGs and it is possible that this would lead to differences in the data. No significant 
difference was found in any of the measurements using a 2 tailed paired t test, for the mean 
pixel intensity values p=0.9985. As no significant difference was found, the higher 
compression JPEG images were used for convenience.  
The five horizontal images and the five vertical images are also used to assess 
reproducibility. Although the images are of slightly different parts of the lens, they are  
analogous to minor differences in scan placement and will be used to assess the test-retest 
reliability of the measurements. If there is little correlation between the five scans taken 
0.25mm apart, the test-retest reliability is likely to be poor. The selected area of each image 
was analysed to record mean pixel intensity, the standard deviation of the mean pixel 
intensity and the integrated density of the selection. 
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5.2.3: Statistical analysis: 
It was determined that a sample size of 40 eyes would be more than sufficient to detect a 
correlation which would be clinically significant, based partly on the sample size chosen by 
Wong et al (2009) of 55 eyes. 
Statistical analysis was performed using Microsoft Excel and IMB SPSS version 20 for 
Windows.  
Statistical significance was chosen at the 0.05 level and one or two tailed tests were chosen 
as appropriate. 
Bland-Altman analysis was used to determine repeatability, correlations were determined 
using Pearson’s or Spearman’s correlation coefficients as appropriate depending on whether 
the data was normally distributed and means were compared using t tests.  
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5.3: Results: 
 
Effect of scan height: 
A set of twelve images of the cornea of two patients at various heights were analysed to 
estimate the effect that scan height has on the pixel intensity. It was found that scan height 
is significantly correlated with mean pixel intensity (r=-0.981, p<0.001). These results were 
graphed (figure 4.12). 
 
 
Figure 5.12: mean pixel intensity against image position in scan window (N=12) 
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Normality Tests: 
The data was first tested using a Shapiro-Wilk test for normality. The mean average of the 10 
measurements from each eye was used for this purpose. Results are displayed in table 5.1: 
Tests of Normality 
 Shapiro-Wilk 
Statistic N Sig. 
MT .893 26 .011 
MPOD .952 27 .237 
NC .822 39 .000 
NO .888 39 .001 
C .888 39 .001 
Age .920 39 .008 
VA .659 39 .000 
Mean .964 39 .244 
Standarddeviation .944 39 .053 
IntDen .973 39 .468 
 
Table 5.1: normality tests. MT=central 1mm macular thickness, NC=nuclear colour, 
NO=nuclear opalescence, C=cortical opacity, mean=mean pixel intensity, Standarddeviation= 
standard deviation of pixel intensity, IntDen= Integrated density of pixel intensity.  
Repeatability 
Three sets of images were assessed to test for repeatability of the images – the second and 
third scans of both the horizontal and vertical sections were compared to test for 
repeatability when images were taken through slightly different parts of the lens as would 
be expected to occur in test-retest conditions and the central scan from the horizontal and 
vertical sections were compared to test for repeatability after repositioning, through a 
different aspect of the lens.  
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A Bland-Altman test of the mean pixel brightness data was used to assess repeatability, 
comparing the central scan with the previous scan placed 0.25mm away. This test was 
performed on both the horizontal and vertical sections. Additionally, the central scan from 
the horizontal and vertical scans were compared against each other in the same way.  
Repeatability, horizontal scans 2 and 3: A one sample t test was performed which showed 
there was no statistically significant difference between the difference between the two 
scans and zero  ( t=1.901p=0.065, CI=-0.0647-2.0604.) The mean difference between the two 
measurements was 0.99 +/-3.28 and the coefficient of repeatability (CR) was 6.42. 
 
 
 
Figure 5.13: A Bland-Altman plot of the difference between the mean of the second and 
third horizontal scans plotted against the mean of the same 2 scans. N=39. 
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Repeatability, Vertical scans 2 and 3: A one sample t test was performed which showed 
there was no statistically significant difference between the difference between the two 
scans and zero ( t=-1.404 p=0.168, CI=--1.5435-.2794). 
The mean difference between the two measurements was -0.63 +/- 2.81 and the CR was 
5.51. 
  
 
Figure 5.14: A Bland-Altman plot of the difference between the mean of the second and 
third vertical scans plotted against the mean of the same 2 scans. N=39. 
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Repeatability, horizontal centre scan Vs vertical centre scan: A one sample t test was 
performed which showed there was no statistically significant difference between the 
difference between the two scans and zero (t=-0.439 p=0.663, CI=-4.2317-.2.7242). 
 
The mean difference between the two measurements was -0.75 +/-10.73 and the CR was 
21.03. 
 
 
Figure 5.15: A Bland-Altman plot of the difference between the mean of the third horizontal 
and third vertical scans plotted against the mean of the same 2 scans N=39 
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Comparison of OCT scan data with LOCS III grading data: 
Several aspects of the OCT scan data were collected: the mean pixel intensity, the standard 
deviation of the pixel intensity, and the integrated density of the images.  
LOCS III data on nuclear opalescence (NO) nuclear colour (NC) and cortical opacities (C) was 
recorded, along with age, VA, MPOD where applicable and MT as automatically measured by 
OCT where applicable.  
The data was analysed using Pearson’s correlation coefficient for data which was normally 
distributed (Mean pixel intensity, standard deviation of pixel intensity, integrated density, C, 
MPOD) and Spearman’s rank correlation coefficient for data which was not normally 
distributed (NC, NO, MT, age, VA).  
Visual Acuity:  
Median VA was 0.1 with a range from -0.1 to 1.0.  
Visual acuity was correlated significantly with all 3 LOCS III measurements, moderately with 
NC and weakly with NO and C. VA was also correlated significantly with MT.  
     C MPOD Mean Standard 
Deviation 
IntDen NC NO MT Age 
                    
VA 
Correlation 
Coefficient 
.328* -0.044 -0.102 0.168 0.12 .534** .418** -.433* 0.255 
Sig. (1 or 2-
tailed as 
appropriate) 
0.021 .0.828 0.538 0.306 0.468 0 0.004 0.028 0.059 
1-
tailed 
 2-
tailed 
2-
tailed 
2-tailed 
2-
tailed 
1-
tailed 
1-
tailed 
2-
tailed 
1-
tailed 
N 39 27 39 39 39 39 39 26 39 
Table 5.2: correlations for VA 
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Age 
The age range of the study was 63 to 89 years  with a median age of 77 years. Age was 
correlated significantly with NC and NO but not with C. Age was inversely correlated with 
macular thickness. Integrated density of the images was also weakly correlated with age  
    C MPOD Mean 
Standard 
Deviation 
Int 
Den NC NO MT VA 
Age Correlation  
Coefficient 
.207 .027 .252 .291* .347* .426** .354* -
.522** 
.255 
Sig. (1 or 2-
tailed as 
appropriate) 
.103 
1-
tailed 
.894 
2-
tailed 
.122 
2-
tailed 
.072 
2-tailed 
.03 
2-
tailed 
.003 
1-
tailed 
.014 
1-
tailed 
.006 
2-
tailed 
.059 
1-
tailed 
N 39 27 39 39 39 39 39 26 39 
           Table 5.3: correlations for age 
MPOD  
Mean MPOD was 0.37 +/- 0.16. MPOD was not significantly correlated with age, macular 
thickness or any of the cataract measurements taken (p>0.05). 
    C Mean 
Standard 
Deviation IntDen NC NO MT Age VA 
MPOD Correlation 
Coefficient 
.285 0.251 .194 .176 .292 .159 .290 .027 -.044 
Sig. (1or 2-
tailed as 
appropriate) 
.232 
2-
tailed 
.394 
2-
tailed 
.332 
2-tailed 
.380 
2-
tailed 
.140 
2-
tailed 
.428 
2-
tailed 
.170 
2-
tailed 
.894 
2-
tailed 
.828 
2-
tailed 
N 27 27 27 27 27 27 24 27 27 
 
Table 5.4: correlations for MPOD 
Mean pixel intensity 
The mean pixel intensity of all the cortex images was 73.87+/-12.06. 
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The mean C value was 2.60 +/-1.02, the median NC value was 2.6 with a range from 1.9 to 
5.9 and the median NO value was 2.4 with a range from 1.8 to 5.9.  
Mean pixel intensity was only significantly correlated with the NC measurement (r=0.324, 
p=0.044) and was not significantly correlated with the C scores (r=0.251, p=0.122) 
 
 
 
 
Table 5.5: correlations for mean pixel intensity 
The standard deviation of the pixel intensity  
The mean value for the standard deviation of the pixel intensity of each image was 34.72 +/-
5.80 The standard deviation of the pixel intensity was weakly correlated with the C scores 
(r=0.354, p=.028) . This measure was not significantly correlated with VA (r=0.168, p=0.153)  
    C NC NO MT Age VA 
Standard 
deviation 
Correlation 
Coefficient 
.354* .409** .190 -.378* .291* .168 
Sig. (2-
tailed) 
.028 .010 .246 .056 .072 .306 
N 39 39 39 26 39 39 
 
Table 5.6: correlations for standard deviation of pixel intensity. 
In addition, NC and NO measurements were significantly correlated with each other, 
(r=0.678, p=<0.001) 
  C MPOD NC NO MT Age VA 
mean Correlation 
Coefficient 
.251 .260 .324* .143 -.176 .252 -.102 
Sig. (1 or 
2-tailed) 
.122 
2-
tailed 
.190 
2-
tailed 
.044 
2-
tailed 
.368 
2-
tailed 
.390 
2-
tailed 
.122 
2-
tailed 
.538 
2-
tailed 
N 39 27 39 39 26 39 39 
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5.4: Discussion 
The results of the corneal scans suggest that the image height has a major effect on the pixel 
intensity for the cornea which may have implications for how the lens cortex images 
measure and display; particularly that cortex depth may affect overall image intensity. 
The LOCS III measurements are all significantly correlated with VA. The strength of the 
correlation is in line with previous studies of LOCS III measurements and VA (Donnelly et al., 
2004; Elliott and Situ, 1998; Wong et al., 2009) 
Macular thickness was correlated with VA as has been found in previous studies (Eriksson 
and Alm, 2009).  
The results suggest that none of the quantitative measurements from 5 line raster scans 
taken with OCT used in his study are good metrics which can be used to grade visually 
significant cortical opacity.  
The standard deviation of the pixel density was significantly correlated with the LOCS III 
cortical opacity score. This may reflect the greater variability of density found in the cortex 
of an eye with cortical cataract but this correlation was weak, only accounting for 13% of the 
variability in the scores and therefore is not a useful grading tool on its own. Furthermore, 
this metric was not as well correlated with VA as the LOCS III C score. The most significant 
correlation with VA is the NC score.  
This highlights the other issue with measuring one aspect of the cataract in isolation which is 
that all the subjects also had other forms of cataract which it would appear were affecting 
their vision as well as, and possibly more than, the cortical cataract. To obtain a reliable 
metric an overall lens density score may be required, but as yet the only OCT instruments 
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capable of imaging the whole lens are experimental, such as the instrument used in figure 
5.5. Other instruments such as those using the Scheimpflug principal can image the whole 
crystalline lens simultaneously, but as these lack the capability to be used in as versatile a 
manner as OCT, it is more likely that OCT technology will advance to the point where whole 
lens imaging is available to practitioners, rather than Scheimpflug instruments become 
commonplace. 
A larger study might be able to isolate the effect of the C from the NC and NO by controlling 
for the effect t of the other types of cataract. 
The Bland-Altman plots show that there is no systematic error between any of the variables, 
with the one sided t test showing no significant difference between the difference between 
the two data sets and zero. However, there is considerable greater variability between the 
horizontal and vertical centre scans than between the second and third scans of either the 
horizontal or vertical data sets, with the CR being considerably larger. This may be explained 
by the nature of cortical cataract which tends to occur in radial ‘spokes’ which if they 
intersect with one set of scans but not the other can give a considerable difference in pixel 
intensity between the horizontal and vertical scans. Part of the variability may also be due to 
the repositioning of the patient that occurs between the horizontal and vertical scan sets, 
but not between the individual scans in a single scan set which is likely to lead to greater 
differences between the two. 
This data suggests that the repeatability of the individual scans is good, but the difference 
between the horizontal and vertical scans can be large. This may be due to the nature of 
cortical lens opacities, indicating that possibly a 200x200 cube scan of the lens cortex may 
give more complete results than single raster scans. Unfortunately these scans tend to be 
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prone to movement artefacts to an extent that the posterior cube scans are not. This is  due 
to greater parallax between the anterior segment and the scanning beam compared to the 
posterior segment and the lack of a movement correction feature on the anterior segment 
scans as is applied to the posterior segment. 
The images taken provide measurements which appear to be repeatable, within the bounds 
of the tests performed. It would be useful to establish repeatability with single identical 
scans with full repositioning to establish how much of the difference between the variability 
of the horizontal and vertical scans is due to repositioning, and how much is due to genuine 
differences in lens density that occur as a result of the spoke patterns of the cortical 
opacities. 
There are a number of reasons for the images not providing useful metrics for cataract 
grading which involve the nature of cortical opacity and the nature of images generated by 
the OCT. Cortical cataract is often different in nature to nuclear cataract, and this may lead 
to difficulties with objective grading. As it is usually less uniform than nuclear cataract, the 
precise placement of the opacities determine the visual effect as well as the density.  
 The nature of the OCT scan is that a dense opacity will cast a shadow on the tissue below it. 
This often means that the image below a dense opacity will be darker than it would be 
without the opacity. This effect can easily be seen on a scan of the retina where blood 
vessels cast a shadow down to the RPE, and RPE atrophy will lead to brighter scan image of 
the vessels of the choroid than can be obtained with an intact RPE.  This tends to mean that 
a lens with a dense opacity to the anterior surface will measure less bright on an OCT scan 
than a lens with identical density but a more posterior opacity. 
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Figure 5.16: a dense central opacity with darker region below caused by shadowing of the 
scan beam. 
 
Figure 5.17: shadows cast by a very dense opacity from a white opaque cataract to the 
extent that the posterior cortex is not visible. 
 
Figure 5.18: the lens in figure 4.17 viewed with a slit lamp.  
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Figure 5.19: a very clear anterior lens which will cause an increase in posterior cortex scan 
intensity and a slit lamp image of the same lens. 
Another issue is the highly variable nature of cortical lens opacities. Nuclear opacities tend 
to manifest as more or less even increases in lens density, ideal to measure with OCT as 
previously demonstrated (Wong et al., 2009). cortical opacities can also manifest as even 
dense opacities, but areas of a lens cortex with cataract can also be very clear, areas known 
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as water clefts. Both of these will cause visual impairment as light tends to be scattered and 
subject to aberrations which cannot be corrected optically but very clear areas of lens will 
not lead to an increase in overall scan density.  
 
Figure 5.20: water clefts  
In addition, any scans which do not pass through the opacity will not record increased 
density. This is also an issue with other measures of cortical opacities such as the LOCS III 
grades, which tend also to correlate poorly with the usual measures of vision used in 
practice. 
Another possible confounding factor is the influence of the cornea on the brightness of the 
scan of the lens cortex. It is possible that anterior chamber depth, corneal reflectivity and 
corneal thickness influence the scan brightness and that inverted images of the cornea 
caused by the nature of the Fourier analysis the instrument uses to produce the images 
could produce artefacts in the cortex images at critical values. The depth of field the Cirrus 
instrument provides is not sufficient to measure anterior chamber depth so this effect could 
not be investigated in this study. The issue identified using the corneal sections that the 
image brightness is heavily dependent on the scan height could potentially overestimate the 
density of the front of the anterior cortex whilst underestimating the density of the back of 
159 
 
the anterior cortex. Further investigation, possibly using a time domain OCT image as 
comparison, may reveal the strength of this effect. 
OCT measurements of lens density are probably accurate enough to measure differences in 
cortex density that occur generally with age, but not to distinguish between different 
degrees of cortical cataract as this causes specific difficulties that are not easily resolved into 
a single metric. The significant correlation between the standard deviation of the pixel 
intensity and the cortical cataract scores gives a hint as to how OCT could give some insight 
into cortical cataract as it provides some measure of the variation in density that is seen on 
the cross sectional images and causes the local variations in refractive index which can cause 
aberrations, However, the correlation is too weak to be useful as a grading on its own.  OCT 
is a useful technology for imaging cataract in a non-invasive way to aid clinical decision 
making in a similar way to slit lamp imaging and produces images which an experienced 
operator can use to assess cortical cataract in ways which slit lamp imaging can sometimes 
be difficult, particularly without pupil dilation. This method may yet become useful when 
instruments become capable of imaging the whole lens as a cube and more complex data 
analysis can be performed. 
Further investigations in this area may include using 200x200 scan cubes to analyse local 
differences in lens density as this may provide information that is difficult to extract from 
individual scans. It is more likely to be an analysis of variations in lens density through a  
single lens rather than absolute variations in density between different lenses which 
provides an index which can be used to grade visually significant cortical cataracts. Other 
analysis which might be useful is comparing OCT measurements with other measures of 
vision such as small letter contrast sensitivity which have been shown previously to correlate 
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better with cataract scores than high contrast letter acuity such as the snellen or LogMAR 
standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
161 
 
5.5: Conclusion 
This experiment concerned the use of a commercial OCT instrument to grade cortical 
cataract. It was found that the standard deviation of the pixel intensity was weakly 
correlated with the LOCS III cortical score. This correlation was statistically significant but not 
strong enough to be useful as a grading tool. 
Ultimately, grading cataract has to consider the lens as a whole if good correlations with 
vision or symptoms are to be sought. Current OCT instruments on the market are not 
capable of performing this task. In the near future instruments which can image the entire 
crystalline lens may become available. This may provide the tools to usefully grade cataract 
using OCT although objective findings, however accurate, may not account for differences 
that are often observed in practice to exist in subjective symptoms between those with 
objectively similar cataracts. 
The next chapter will summarise the findings of the experimental chapters and explore the 
implications for the results and possible future directions for research. 
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Chapter Six 
General Conclusion 
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The previous three experimental chapters have explored the effect of pseudophakia on 
MPOD, the relationship between macular thickness and MPOD and the use of OCT to image 
and grade cortical cataract. This chapter will summarise the reasons the experiments were 
conducted, the findings of the experiments and possible directions for future research.   
 
In an aging population, age related eye diseases are becoming more common and most 
people will be affected to some extent by cataract and many by AMD (Evans and Wormald, 
1996). Recent advances in IOL technology and an increasing market for elective lens 
replacement for refractive reasons are also meaning more people are having cataracts 
removed earlier, and with increasing life expectancy can expect to live longer afterwards. 
The implications of this are not fully understood, but research indicates that removing the 
natural crystalline lens and replacing it with a clear, UV blocking IOL increases the risk of 
AMD (Chakravarthy et al., 2010). This is likely to be due to the increase in light exposure to 
the retina and in particular blue light as well as possible activation of inflammatory processes 
in susceptible people (Cuthbertson et al., 2009). One of the possible mechanisms behind this 
is degradation of the MP by the increased light exposure, reducing both the barrier 
protection and antioxidant protection that MPOD is thought to provide.  
New instruments to measure MPOD such as desktop HFP instruments and new instruments 
to measure physical parameters of the macula such as spectral domain OCT can provide 
insights into the in vitro behaviour of the aspects of the macula investigated in this study. 
Spectral domain OCT can also be used to examine the cataract itself, which provides a novel 
way to examine this common age related disease with the potential to extract data not 
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easily available from slit lamp examination. Initial trials to examine the lens cortex with OCT 
showed that images could be produced of the lens cortex which appeared to correlate well 
with cross sections of the lens obtained through slit lamp examination, so the question of 
whether these images could be used to objectively grade cataract in a way which correlate 
well with other methods of cataract assessment was raised.  
At the time this study was devised, few studies had been performed which attempted to 
compare MPOD in eyes with different levels of light exposure, and those where the two 
variables had been compared were subject to possible confounding factors. An experimental 
design which compared MPOD in eyes which were subject to exactly the same conditions 
save light exposure was proposed, and the one common procedure which is often carried 
out monocularly and affects retinal light exposure levels is cataract removal. A study was 
therefore devised to compare levels of MPOD with a procedure which has been proven not 
to be affected by the removal of cataract in the short term, HFP. Subjects who had one of 
their cataracts removed were recruited and MPOD compared between the two eyes.  
This study design has some potential confounding factors such as there being  a pre-
operative difference in MPOD or a physical difference between the eyes which leads to both 
low MPOD and cataract but in general there are different confounders to those in previous 
studies. This study design therefore offers an original contribution to knowledge as to the 
differences in MPOD between a phakic eye and a pseudophakic eye 
The subjects of these two studies were all being examined with OCT to examine the macula 
as this is an excellent way to assess macular health and this provides thicknes s 
measurements of the macula which can be used as a proxy for macular health, as macular 
thickness has been previously shown to decline with age and macular disease (Eriksson and 
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Alm, 2009; Liu et al., 2011). A further investigation was devised to use this data to compare 
these parameters with MPOD as previous studies in this area have been inconclusive and 
many had used time domain OCT with a lower resolution than SD-OCT.  
The three main questions posed by this study were therefore:  
1) Does pseudophakia affect MPOD? 
2) Is MPOD correlated with macular thickness? 
3) Can SD-OCT be used to measure cortical cataract severity? 
Chapter three dealt with the question of whether MPOD is affected by the presumed 
increased retinal light exposure that results from cataract removal and implantation of a 
visible light clear IOL. In the time whilst this study has been being conducted, two othe r 
studies have asked the same question, albeit using substantially different methods, and have 
come to the conclusion that MPOD is lower in pseudophakic eyes than the fellow phakic eye, 
and this study comes to the same conclusion. This represents a substantial body of evidence 
that MPOD is reduced by pseudophakia. The most likely reason for this effect is the 
increased light exposure. This outcome makes it likely that reduced MPOD may be in part 
responsible for the increase in macular degeneration rates previously reported following 
cataract removal.  
There are several implications of this result. The first is that it strengthens the case for using 
blue blocking IOLs during routine cataract surgery, particularly in patients with signs of AMD 
and young patients who can expect a considerable lifespan post operatively. Secondly, it 
strengthens the advice often given postoperatively that eye protection from sunlight is 
desirable, namely sunhats, sunglasses and general sun avoidance. Thirdly it implies that light 
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exposure is likely to be a risk factor for macular degeneration regardless of whether the 
person is pseudophakic and fourthly it indicates that, particularly for those with low dietary 
carotenoid intake, dietary modification or supplementation may protect against AMD, 
particularly following a cataract removal.  
The use of blue blocking lenses has been controversial with disputes over their use. It has 
been proposed that blue blocking lenses could affect colour vision, circadian rhythm and 
scotopic sensitivity (Mainster MA, 2005). These concerns are unlikely to be well founded. A 
blue blocking IOL still transmits similar levels of blue light as the natural lens of a 50 year old 
and therefore although relative to a clear IOL the level of transmitted blue light is low, it is in 
the vast majority of cases going to be higher than the levels of blue light the cataract 
removed was transmitting (Romano et al., 2011). In addition, one recent study found no 
difference in scotopic sensitivity or colour vision between the two eyes of subjects who had 
one blue blocking IOL and one clear IOL (Kara-Junior et al., 2011). The question of whether 
blue blocking lenses have any benefit remains unanswered and as they are more expensive 
than clear IOLs the cost-benefit ratio is uncertain. A large scale long term study of AMD 
progression on those implanted with blue blocking IOLs and clear IOLs would be useful to 
answer this question. Such a study could be used also to measure the effect of pseudophakia 
and blue blocking lenses on MPOD, preferably using both psychophysical and objective 
methods. 
The recommendation to use sunhats, sunglasses and L, Z and MZ supplements after a 
cataract operation also has an uncertain cost benefit ratio, although in this case the costs are 
borne directly by the subject rather than by the health service provider. Many patients find 
the increase in light levels after cataract removal necessitate the use of sun protection in any 
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case. The effect of dietary supplements of L Z and MZ for pseudophakics has not been 
investigated and therefore although there is a theoretical basis for advising their use any 
recommendation must be with the caveat that there is a lack of evidence in this area. 
There are several directions that this research could potentially lead. The response to 
supplementation in pseudophakics would be interesting to determine, in order to see if 
supplementation with L Z and MZ has a greater relative effect on MPOD than it does in 
phakics. It may be that there is a homeostatic mechanism for replacement of MP but in 
pseudophakics it is overwhelmed. It would also be interesting to see if the result here is 
consistent across different genetic groups. There appear to be racial differences in MPOD 
which could lead to differences in MPOD response to photooxidation or metabolic oxidative 
stress. It may be that Nolan et al (2009) studied a group of people with a more effective 
response to degradation of MP than the groups studies by Obana et al (2011) and Demirel et 
al. (2009) and the group of subjects studies here leading to the different conclusions. 
The measurements taken with the OCT and MPS instruments during this study enabled 
investigation into other possible limiting factors on MPOD such as retinal architecture, which 
leads into the investigations carried out in chapter three.  
In Chapter four the relationship between MT and MPOD was investigated.  Current evidence 
is inconclusive, but this is the first study which has looked at the entire macular area as 
opposed to just the fovea or central macula where the MP accumulates (see table 2.2).  This 
research indicates that the thickness of the entire macular area is correlated with MPOD, 
and that all measures of macular thickness decline with age. It did not find that central or 
foveal macular thickness measurements are significantly correlated with MPOD.  
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This result indicates that macular thickness and MPOD decline together, but it is unlikely that 
they are dependent on each other. It is likely that both decline as a function of macular 
health, possibly as MP uptake is reduced in a retina which is under stress. This could be due 
to the RPE becoming less efficient at the uptake and transport of MP as the cellular 
machinery ages. Alternatively greater oxidation in an aging RPE due to lipofuscin 
accumulation could denature the MP faster, leading to less being present in the retina.  
This makes it less likely that the MPOD in the retina is governed by the availability of binding 
sites but that factors which affect macular thickness  also affect the ability of the RPE to 
transport MP into the retina or people with low serum levels of MP also tend to have thinner 
maculae. Further investigation is required to determine which of these is the case. The result 
here must be viewed with the limitations of the study in mind, in particular the small sample 
size, the multiple comparisons made and the degree of correlation found which was not 
particularly strong. This investigation has revealed a possible area for further study but 
cannot be taken as conclusive in isolation. A larger scale study would be required to confirm 
if the effect found here can be replicated.  
Further research in this area is required to understand the factors which govern MPOD levels 
in the retina and the cause effect relationship between them. Previous research has found 
that macular width is associated with MPOD differences and that there are differences in the 
relationship between macular measurements between races (Nolan et al., 2008). The 
relationship between the variables may be complex and it may be that the limiting factors 
for MPOD differ between individuals. It is possible that in some the ability to transport MP 
into the retina is a limiting factor and in others the thickness and distribution of binding s ites 
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is the limiting factor. It may also be the case that the factors which govern MPOD are 
different in a healthy and a diseased retina.  
A long term study of macular thickness in those who have had their cataracts removed and 
replaced with clear IOLs may give worthwhile insights into changes in macular thickness in 
those with lower MPOD but it is likely that such studies would need to be conducted in those 
who have been pseudophakic for more than five years as Kara-Junior et al (2011) have 
already found no effect over five years. This could be conducted as a longitudinal study, 
though dropout rates may be an issue, or it could be conducted as a cross sectional or case 
control study, though problems of confounding factors can be an issue. 
The OCT instrument used to obtain the retinal measurements used in this part of the study 
does so by providing images which are graded on reflectiveness which is used in this case to 
delineate the retinal layers, as different tissues have different levels of reflectiveness.  An 
important aspect of interest in the design of the study detailed in chapter two is that the 
optical density of the lens increases with age as cataract develops.  
Wong et al (2009) have found that time domain AS-OCT images can be used to grade nuclear 
cataract density, but no studies have attempted to use SD-OCT designed for posterior 
segment imaging for this purpose and no studies have attempted to grade cortical cataract 
using OCT. It was proposed that these instruments could be used to obtain images of the 
lens cortex and the optical density of these images as displayed by the instrument might be 
used to grade cortical cataract, and this leads us to chapter four.  
Chapter five investigated whether objective grading of cortical cataract could be carried out 
using a commercial OCT instrument primarily designed for posterior segment imaging, the 
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Zeiss Cirrus OCT (Zeiss Meditec, Jena, Germany). Cross sectional images of the lens cortex 
were successfully obtained from a number of subjects with a range of cortical cataract 
grades and these were compared using image analysis software to conventional grading 
techniques and to visual acuity measurements. Though the images obtained were 
repeatable, it was found that the image density correlated poorly with either t he LOCS III 
cortical cataract grade or to the visual acuity of the subject. Several reasons were found for 
this result, some of which are specific to the type of cataract and some to the properties of 
SD-OCT.  The variability of the density of the lens in cortical cataract presents a challenge 
when grading as the overall density of the lens may not reflect the effect it has on the vision 
of the patient. SD-OCT instruments are also prone, as Scheimpflug instruments are, to 
shadowing from dense opacities affecting the overall lens density.  
These difficulties may be overcome as the technology progresses. There is potential for OCT 
to be a useful technology in the investigation of cataract in the future and it can be used to 
obtain sectional images through the lens which might be able to be used to chart the change 
in lens density in an individual over time.  
These investigations further our knowledge of the behaviour of MP in vivo, the changes that 
occur in the macular and the lens of the aging eye and the potential and limitations of 
spectral domain optical coherence tomography as a tool in general optometric practice. 
They have in this respect accomplished the objectives of the thesis. 
There are further research questions that lead from this research. As OCT instrumentation 
develops, continued investigations into assessment of cataract could prove useful as the 
limitations of the instruments revealed in this study are overcome. Instruments which obtain 
images of the whole lens and instruments which correct for the artefacts inherent in SD-OCT 
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instruments such as the reflected secondary image and the relationship between the scan 
height and the image brightness would be key to solving the issues identified here.  
Further research is needed to establish whether any feedback mechanism for replacement 
of MP exists and how blue blocking lenses influence the MPOD postoperatively as current 
research is contradictory. Current research points towards MPOD reducing with both blue 
blocking and clear IOL implantation with blue blocking lenses reducing this effect but with a 
limited number of studies so far this is not certain. These investigations may be through the 
investigation of the cell chemistry of the RPE, larger studies investigating MPOD over longer 
timescales after cataract removal and investigations into the relative effect of 
supplementation on those with cataract and those who are pseudophakic. For example, if a 
feedback between light exposure and MP uptake exists, it might be expected that the effect 
of supplementation would be greater on a pseudophakic eye than a fellow eye in the same 
subject with cataract. Long term epidemiological studies which assess light exposure more 
accurately than retrospective questionnaires might also be useful . These could possibly 
involving new technology trends such as wearable video cameras to actually measure light 
exposure over time or comparing MPOD over time in people who move to significantly 
different latitudes to investigate the relationship between light exposure and MPOD. 
Further research into the effect of foveal architecture on MPOD might include larger scale 
studies into the relationship found here between average macular thickness and MPOD and 
whether in larger scale studies a significant relationship between foveal and central macular 
thickness in the same eyes where a change in average thickness is found. It would also be 
useful to confirm using objective techniques the effects found using HFP here. OCT could be 
also used to measure specific retinal layers to identify i f the thinning observed here occurs in 
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all retinal layers or if it more specific. Further investigations may also attempt to discover if 
chronic high light exposure causes retinal thinning or if the effects of light exposure on 
MPOD and the relationship between MPOD and retinal thickness are independent.  
As OCT technology progresses the limitations of the instrument found here in the grading of 
lens opacities may be overcome to some extent. A scan of the density of the entire thickness 
of the lens, over the lens area exposed by the pupil may give useful measurements of lens 
density which may relate to vision. If the disadvantages of current instruments are overcome 
and future instruments have the ability to measure density irrespective of scan height or 
shadowing the methods used here might yield more useful results. Investigation of how 
these measurements correlate to other methods of assessing vision in cataract such as 
contrast sensitivity, symptoms and glare may also provide some insight into whether OCT 
can be used to assess patients for cataract removal in an objective way. 
Access to new technology in the practice of primary care practitioners such as OCT and 
desktop MPOD measuring instruments is leading to new ways in which these practitioners 
can investigate the health of their patients’ eyes and advise them on how they might best 
maintain their vision. It also provides a potential reservoir of information which can be used 
for research but is currently largely untapped. It is vital that primary care practitioners have 
up to date information on how procedures like cataract removal may affect the future visual 
status of their patients. 
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Appendix 1: correlation graphs for chapter three: 
Appendix 1.1: Average MPOD values plotted against age. N=25 
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Appendix 1.2: The difference in MPOD values between pseudophakic and phakic eyes 
plotted against the time since operation. N=25 
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Appendix 1.3: The difference in MPOD values plotted against time since operation up to 100 
months. N=20 
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Appendix 1.4: Macular thickness values plotted against age. avt is the thickness over the 
entire 6mm diameter area, mt is the thickness of the central 1mm diameter of the macula 
and ft is the central thickness of the fovea. N = 43 eyes. 
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Appendix 1.5: MPOD plotted against average macular thickness  over the 6mm diameter area  
N= 41 eyes. 
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Appendix 2: Ethical Approval  
 
 
 
Response from AOREC 
 
4th March 2011 
 
Our Ref: AO2010.21 
Project title: Assessment of the long term effect of cataract removal on the level of macular 
pigment as measured by heterochromatic flicker photometry and variations in macular 
thickness related to macular pigment levels 
Application Number: AO2010.21.R2 
Researchers:  Professor James Wolffsohn, Mr Martin Smith  
Ophthalmic Research Group 
  Aston University, B4 7ET 
 
Dear Professor Wolffsohn, 
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On behalf of the Audiology/ Optometry Research Ethics Committee (AOREC), I am pleased to 
inform you that the AOREC are happy to give approval to the above study and the following 
documents: 
 Research Protocol macular pigment and OCT final revised after reviewer.docx (dated: 
25th February 2011) 
 Consent_form_martin_smith_revised after reviewer.docx (dated: 25th February 
2011) 
 
The details of the investigation will be placed on file. You should notify the Committee of any 
difficulties experienced by the volunteer subjects, and any significant changes which may be 
planned for this project in the future.  
 
Yours sincerely, 
 
 
 
Dr Leon N. Davies 
Chair AOREC 
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Appendix 3: Patient information sheet. 
Research workers, school and subject area responsible 
 
Mr. Martin Smith, School of Life & Health Sciences, Optometry, Aston University, 
Birmingham. 
 
 
Project Title 
 
Assessment of the long term effect of cataract removal on the level of macular pigment as 
measured by heterochromatic flicker photometry and variations in macular thickness 
related to macular pigment levels. 
 
Invitation 
 
You are being invited to take part in a research study.  Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully.  
 
What is the purpose of the study?  
 
The purpose of this study is to determine whether cataract removal has any effect on the level 
of pigment in the macular region of the retina. This pigment is important for detailed vision. 
We also want to know if there is a relationship between macular pigment levels and retinal 
thickness. The levels of this pigment may be affected by the increase in light levels reaching 
the retina in an eye with an artificial lens which is implanted during a cataract operation. 
Macular pigment protects the retina from blue light damage and low levels may be harmful in 
the long term. 
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Why have I been chosen? 
 
You have been chosen because you have an artificial lens in one eye and a natural lens in the 
other. 
 
 
What will happen to me if I take part? 
 
By volunteering to participate you will be invited to perform a quick, painless test similar to 
the visual field examination which you perform during your normal eye test called an MPOD 
test which determines how dense the pigment in the macular region of your eyes is. The test 
will take about around 10 minutes and will be performed twice on each eye with a short gap 
in between. The test involves detecting flickering lights on a screen. The measurement of 
macular thickness involves a very quick, painless test called Optical Coherence Tomography 
which scans the back of the eye with red light. You will only need to do these tests on a single 
visit to the practice which will usually be during your routine sight test or at an alternative 
time to your convenience if you prefer. You will also be giving everybody in the research team 
consent to analyse your results and compare them other people. If the tests show any 
deficiency in macular health or pigment levels appropriate advice will be offered on how to 
you. 
 
Are there any potential risks in talking part in the study ?  
 
There is a risk of breaching privacy and confidentiality in relation to your test data. This will 
be minimised by keeping your data anonymous at all times. As a member of practice staff, 
Mr. Smith has access to your patient records. He will be responsible for putting your results 
onto a database and maintaining your privacy and confidentiality. Other members of the 
research team will only be given access to the database after your identity has been 
removed from it. The procedures themselves are painless and cannot cause any harm. 
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Do I have to take part? 
 
No, you do not have to participate if you do not wish to do so. You are free to withdraw at any 
time from the project without reason or explanation.  
 
Expenses and payments: 
 
There are no expenses or payments for participation in this project. 
 
Will my taking part in this study be kept confidential? 
Yes, your participation in the study will be fully confidential. There will be no way to link any 
research data to any individual participant. Research data will be destroyed after 7 years. 
 
What will happen to the results of the research study? 
We aim to publish the results of this research.  However, there will be no reference to any 
individual’s results in any publication. Copies of the published research will be available on 
request to all patients. 
 
Who is organising and funding the research ? 
 
Martin Smith Opticians Ltd. 
 
Who has reviewed the study? 
 
The research has been approved by the Audiology and Optometry Research Ethics Committee 
at Aston University. 
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Who do I contact if something goes wrong or I need further information?  
 
Please feel free to contact Martin Smith on 01522 521100 or 
martin@martinsmithopticians.co.uk or Prof James Wolffsohn on j.s.w.wolffsohn@aston.ac.uk  
 
Who do I contact if I wish to make a complaint about the way in which the research is 
conducted? 
 
If you have any concerns about the way in which the study has been conducted, then you 
should contact Secretary of the University Research Ethics Committee on 
j.g.walter@aston.ac.uk or telephone 0121 204 4665.  
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Appendix 4: Volunteer consent form 
 
Assessment of the long term effect of cataract removal on the level of macular pigment as 
measured by heterochromatic flicker photometry. 
 
Name of Chief Researcher: Mr. Martin Smith 
 
  Tick Box 
1 I confirm that I have read and understand the information sheet for the 
above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2 I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical care 
or legal rights being affected. 
 
3  I agree to take part in the above study.   
 
 
 
 
_________________________ ________________ ___________________ 
Name of volunteer Date Signature 
 
 
 
 
 
 
   
